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DNA Polymerase ε: Replication Error Prevention and
Consequences of a Cancer-Associated Mutation
Chelsea R. Bulock, Ph.D.
University of Nebraska, 2020
Supervisor: Polina V. Shcherbakova, Ph.D.
Genome integrity is necessary to prevent mutations and disease. During
eukaryotic DNA replication, DNA polymerases ε (Polε) and δ (Polδ) synthesize the
leading and lagging strand, respectively. Polε and Polδ also have exonuclease activity
that acts in series with post-replicative mismatch repair (MMR) to remove replication
errors. Defects in proofreading and MMR lead to an increase in mutations and cause
cancer in humans. This dissertation focuses on several unresolved issues involving the
relationship between Polε and Polδ in replication error avoidance. First, despite an
abundance of data supporting the one-strand-one-polymerase replication fork model,
defects in the fidelity of Polε have a much weaker impact on mutagenesis than
analogous Polδ defects. It has been proposed, but not directly tested, that Polδ
contributes more to mutation avoidance because it proofreads mismatches created by
Polε in addition to its own errors. In this work, we sought to explicitly test this idea.
Second, the most common cancer-associated Polε variant, P286R, has recently been
discovered to possess unusual and puzzling properties. Despite the location in the
exonuclease domain, it produces a mutator effect far exceeding the effect of Polε
exonuclease deficiency. The purified yeast analog, Polε-P301R, has increased DNA
polymerase activity, which is thought to underlie its high mutagenicity, but the exact
mechanism remains unclear. We aimed to investigate the impact of the P301R
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substitution on the function of Polε as the leading strand polymerase, and the removal of
Polε errors by error correction mechanisms in vivo.
To test the hypothesis that Polδ proofreads errors made by Polε, we measured
mutation rates in yeast strains harboring a nucleotide selectivity defect in one
polymerase and a proofreading defect in the other. We show that Polδ can proofread
errors made by Polε, but Polε cannot proofread errors made by Polδ. To investigate the
role of Polε-P301R at the replication fork, we measured the accumulation of strandspecific replication errors across a well-defined replicon in yeast. We found that, despite
exceptional polymerase activity, Polε-P301R is a dedicated leading strand polymerase.
We further show that both Polδ proofreading and MMR remove errors incorporated by
Polε-P301R and are required for viability of Polε-P301R cells. In summary, by
demonstrating Polδ-dependent extrinsic proofreading, we resolved the discrepancy
between the one-strand-one-polymerase model and the stronger impact of Polδ defects
on genome stability. Using the hyperactive Polε-P301R, we further demonstrate the
unexpected ease of polymerase exchange in vivo and its critical role in preventing
catastrophic accumulation of errors on the leading strand. Our results also explain the
apparent incompatibility of Polε variants and MMR defects in cancers.
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Chapter 1: Introduction
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DNA replication in eukaryotes
DNA replication is an essential process in every cell cycle, and it must be
completed both accurately and efficiently to produce two identical daughter cells. The
synthesis, or S phase of the cell cycle is tightly regulated to ensure that the cell
completes DNA replication properly prior to mitotic cell division. Replication is initiated at
DNA replication origins, which must be licensed prior to entrance into S phase, and
activated only once S phase has begun. Although the general mechanisms of DNA
replication are conserved in all eukaryotes, the discussion below will focus on DNA
replication in the budding yeast Saccharomyces cerevisiae.

Series of events and required factors
In eukaryotic cells, replication origin licensing involves the binding of a complex
of proteins termed the origin recognition complex to specific DNA regions during G1
phase of the cell cycle (1). In Saccharomyces cerevisiae, these include the proteins
Orc1-6, Cdc6 and Cdt1 (2). This is followed by loading of a hexamer of MCM proteins, a
required component of the helicase which will eventually unwind the duplex DNA, to
establish the pre-replication complex (3,4). Origin licensing must be complete before the
start of S phase, and prevented from occurring again during S phase, which would result
in re-replication, replication stress, and potentially aneuploidy (5). Once origins have
been licensed and S phase has begun, cell cycle kinases CDK and DDK phosphorylate
the pre-replication complex, recruiting the remaining components of the helicase,
including Cdc45, GINS, and DNA polymerase ε (Polε) to form the pre-initiation complex
(6,7). At this point, replication origins are activated and the helicase begins to unwind the
DNA, allowing DNA synthesis by DNA polymerases to proceed. Importantly, only a
subset of licensed origins are activated in a given cell cycle (8). This appears to allow
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the cell greater control over replication timing and responses to DNA damage and
replication stress. Activation, or firing, of origins is strictly regulated spatially and
temporally to produce exactly two identical copies of the genome (2,5,8-11). Replication
timing and origin firing vary depending on the species, cell type and differentiation state
of the cell (2,10). DNA synthesis then proceeds bidirectionally from origins, and
replication forks merge forming replication termination zones. In S. cerevisiae, the
location of termination zones depends on the timing of the firing of the two replication
origins converging, but is generally at the midpoint between efficient replication origins
(12).

Replicative polymerases and their functions
Eukaryotic DNA replication requires three DNA polymerases: Polα, Polδ, and
Polε (13). The model was originally proposed by Morrison and co-authors (14) and
remains the most widely accepted model at this time (Figure 1.1). It suggests that Polαprimase creates short RNA-DNA primers at replication origins and at the beginning of
each Okazaki fragment on the lagging strand, Polδ synthesizes the remaining portion of
Okazaki fragments, and Polε synthesizes the bulk of the leading strand.
Pols α, ε, and δ belong to the B family of DNA polymerases [(9), Figure 1.2]. S.
cerevisiae Polα-primase complex consists of Pol1, Pol12, Pri1, and Pri2. The Pri1
subunit contains the primase activity, and the Pol1 subunit contains DNA polymerase
activity (15). Polα synthesizes approximately 30 nucleotides at replication origins and the
beginning of each Okazaki fragment (~10% of the genome), yet much of the Polαsynthesized DNA is removed by processing of Okazaki fragments (16). Recent analysis
of ribonucleotide incorporation by a variant Polα suggested that only 1.5% of the mature
genome consists of Polα-replicated DNA (17). Polε consists of the catalytic subunit Pol2,
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Leading
strand

Polε
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Figure 1.1. Replication fork model.
Polα-primase synthesizes primers at replication origins and the beginning of each Okazaki
fragment on the lagging strand. Polε synthesizes the leading strand continuously, whereas Polδ
synthesizes the remainder of Okazaki fragments on the lagging strand.
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Figure 1.2. Catalytic and accessory subunits of three replicative DNA polymerases of S.
cerevisiae.
Polα-primase contains primase activity in Pri1, and polymerase activity in Pol1, as well as two
accessory subunits (Pol12 and Pri2). Polε contains catalytic subunit (Pol2) and three accessory
subunits (Dpb2, Dpb3, and Dpb4). Polδ contains catalytic subunit (Pol3) and two accessory
subunits (Pol31 and Pol32).
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and three accessory subunits Dpb2, Dpb3, and Dpb4 (15). Pol2 contains an N-terminal
portion and C-terminal portion, connected by a flexible linker region (18), though this
region appears to be rigid in the presence of Dpb3 and Dpb4 (19). The DNA polymerase
activity is located in the N-terminal portion, which also contains 3’-5’ exonuclease activity
for proofreading of replication errors. The C-terminal portion contains a second,
inactivated exonuclease-polymerase module (20). While Pol2 is required for viability in
yeast, the N-terminal portion is not, although strains lacking the N-terminus of Pol2 are
very sick (21). The C-terminal portion of Pol2 is necessary for DNA replication, as it
forms part of the helicase complex CMGE (Cdc45, Mcm2-7, GINS, and Pol ε) (7). S.
cerevisiae Polδ consists of catalytic subunit Pol3 and accessory subunits Pol31 and
Pol32 (15). Pol3 contains both DNA polymerase and 3’-5’ exonuclease activities, and is
required for viability (22). In addition to their vital roles in DNA replication, both Polε and
Polδ have also been implicated in various forms of DNA repair (23).

Prevention of DNA replication errors
Accurate DNA replication is the primary defense against mutation accumulation
in cells. Elevated mutation rates contribute to genome instability and oncogenesis.
Replicative DNA polymerases are responsible for the selection of correct nucleotides
during DNA synthesis and exonucleolytic proofreading of errors, thus being a major
safeguard against genome instability (24). Rare errors missed by the nucleotide
selectivity and proofreading functions of replicative polymerases are further corrected by
the DNA mismatch repair (MMR) system (25), ultimately resulting in a low mutation rate
of 2.6x10-10 and 3.3x10-10 per base pair in prokaryotic and eukaryotic genomes,
respectively (26). Nucleotide selectivity, proofreading, and MMR act in series to ensure
accurate DNA replication (Figure 1.3).
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Figure 1.3. Replication error avoidance pathway.
Replicative polymerases accurately select correct nucleotides for incorporation (top). In the event
a wrong nucleotide is incorporated, polymerases can remove the error by proofreading (middle).
If an error is missed by proofreading, it can be corrected by post-replicative DNA mismatch repair
(bottom).
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Nucleotide selectivity
The highest contribution to DNA replication fidelity comes from the nucleotide
selectivity of DNA polymerases. The error rates of exonuclease-deficient Polε and Polδ,
measured in vitro are 1.6 x 10-4 and 1.3 x 10-4 mutations per nucleotide, respectively
(27,28), although it has been suggested that the error rates could be lower in vivo (29).
When the structure of DNA was first proposed, it was suggested that the specific
hydrogen bonds formed between the base pairs could serve as a mechanism for making
an exact copy of DNA (30,31). However, measurements of the free energy differences
between correct and incorrect base pairs did not fully account for the extremely high
selectivity of DNA polymerases (32). It was later demonstrated that hydrogen bonds and
base stacking interactions both play a role in maintenance of the structure of DNA, but
the geometric fit of the newly forming base pair to the active site in DNA polymerases
provides the greatest nucleotide selection (32-34). To differentiate between hydrogen
bonding and geometric contribution to nucleotide selectivity of DNA polymerases, base
analogs that lack hydrogen bonding capability but maintain the same shape were used
in in vitro polymerase assays. Difluorotoluene is a thymine analog that lacks hydrogen
bonding capacity. It does not spontaneously pair with adenine in solution, yet Klenow
fragment inserts it across from template adenine and not across from template thymine,
cytosine, or guanine (35,36). Studies using other base analogs provided further support
for the geometric fit hypothesis (36-41). In addition to selecting the correct base, DNA
polymerases must discriminate between ribonucleotides and deoxyribonucleotides.
Studies involving altered polymerases illuminated a specific region of the polymerase
responsible for selection of the correct sugar (42).
Given the tight geometric fit necessary for accurate nucleotide selection, point
mutations that alter the structure of the catalytic site of DNA polymerases would be
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predicted to alter fidelity. Both mutator and antimutator polymerase variants have been
isolated, containing substitutions in the polymerase domain predicted to affect the
geometry of the catalytic site (43). The L868F substitution in Polα occurs at a structurally
conserved position in the polymerase domain and affects the fidelity of the polymerase
(44). Analogous mutations affecting Polδ (pol3-L612M) and Polε (pol2-M644G) also
decrease the fidelity of the replicative polymerases, while leaving exonuclease activity
intact (45,46). Both variants result in increased base-base mismatches in vitro and in
vivo, as well as increased incorporation of ribonucleotides into DNA (47).

Proofreading
After nucleotide selectivity, the next highest contributor to replication fidelity is
exonucleolytic proofreading. Because Polδ and Polε possess exonuclease activity, they
are significantly more accurate than Polα (48-50). The proofreading capabilities of Polε
and Polδ decrease the in vivo replication error rate in yeast by 160-fold and 1000-fold,
respectively (29). The proofreading domains of the replicative polymerases contain three
conserved motifs, Exo I, Exo II, and Exo III (51). Mutations that inactivate the metal ioncoordinating residues in the Exo I motif of Polε (pol2-4) and Polδ (pol3-01) result in
proofreading-deficient polymerases (52,53). Similarly, an aspartate to valine substitution
in the Exo III motif of Polδ (pol3-D520V) also results in a proofreading-deficient Polδ
(54). Antimutator variants of polymerases have also been isolated that reduce replication
errors by altering the balance between nucleotide incorporation and excision (43,55).
Polε can switch processively (without dissociating) from synthesis to
proofreading, although it dissociates after approximately one out of every three
misincorporations (56). Intramolecular switching between polymerase and exonuclease
active sites has also been suggested for Polδ (57). The exonuclease activities of Polε
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and Polδ have been shown to be important for removal of base analogs such as N6hydroxylaminopurine (HAP) (58). Polδ exonuclease activity can also compensate for
lack of flap endonuclease Rad27 during Okazaki fragment processing (54). Another
study found that combining of deletion of EXO1, a 5’-3’ exonuclease involved in MMR,
and Polδ proofreading deficiency resulted in a synergistic increase in the mutation rate
of a long homonucleotide run, and suggested possible involvement of Polδ exonuclease
in MMR (59). As originally hypothesized in the 1970s (60), mutations affecting the
proofreading domains of the replicative DNA polymerases have recently been implicated
in sporadic and hereditary cancers (61).

Mismatch repair
MMR is responsible for removal of DNA replication errors missed by the
proofreading activities of the replicative polymerases. The proteins involved in MMR are
conserved throughout prokaryotes and eukaryotes (62). In yeast, a mismatch is first
recognized by one of two heterodimers, Msh2-Msh6 or Msh2-Msh3 (62). Msh2-Msh6 is
responsible for recognizing base-base mismatches and single-nucleotide loops, whereas
Msh2-Msh3 primarily recognizes single-nucleotide and larger loops, and, to a lesser
extent, base-base mismatches. The binding of a second heterodimer consisting of Mlh1
and Pms1 results in an incision on the nascent strand. This is followed by excision of the
mismatch, usually by Exo1. Polδ, or possibly Polε, re-synthesize the DNA before
ligation.
The timing of MMR is coupled to DNA replication to allow for nascent strand
discrimination and correction of errors prior to mitosis (63). Yet, MMR does not correct
errors uniformly throughout the genome. Microsatellites are short repeat sequences of
DNA found in various locations across the genome. MMR is very efficient in repairing
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insertions and deletions at microsatellites. Accordingly, cells lacking MMR are
microsatellite instable, meaning they have increases in mutations in these repeat
sequences (64). Wild-type strains demonstrate variation in microsatellite stability across
the genome, but inactivation of MMR by deletion of MSH2 eliminated this variation (65).
MMR of 8-oxoguanine-containing mismatches in ogg1Δ strains occurred with better
efficiency on the lagging strand (66). Inactivation of MMR by deletion of EXO1 (63,67)
and MSH2 (68) resulted in a larger increase in lagging strand mutations than leading
strand mutations. MMR has a higher efficiency near origins on the leading strand and in
early replicating regions of the genome (68). MMR also possesses a bias in the type of
errors that are repaired, with the highest efficiency of repair for mispairs that lead to
CT mutations and lowest efficiency for mispairs that lead to AT mutations (68).

Evidence for the DNA replication fork model
During the three decades that passed since the landmark publication by Morrison
et al. (14) proposing the currently accepted replication fork model, numerous reports
have contributed evidence for the participation of Polε and Polδ in leading and lagging
strand replication, respectively. Several genetic studies detected strand-specific
increases in mutagenesis in yeast and human cells carrying inaccurate Polε or Polδ
variants. Experiments using proofreading-deficient polymerase variants demonstrated
that the exonucleases of Polε and Polδ corrected errors induced by base analog N6hydroxylaminopurine (HAP) on opposite strands near a defined replication origin (58).
Two studies using mutator variants of Pols ε and δ utilized the bias in the formation of
reciprocal mispairs by the variant polymerases, and a reporter allele placed near a
defined replication origin, to assign Polε to the leading strand and Polδ to the lagging
strand (46,69). Deep sequencing of a yeast strain carrying a mutator Polδ assigned Polδ
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to synthesis of the lagging strand, with strongest evidence near replication origins (70).
Analysis of mutations in human tumors carrying Polε variants found that abrupt switches
in strand specificity of mutagenesis coincided with replication origins (71). More sensitive
assays monitoring ribonucleotide incorporation into DNA by Polε or Polδ variants with
relaxed sugar selectivity confirmed ribonucleotide accumulation in the leading strand in
Polε mutants and in the lagging strand in Polδ mutants (72,73). Polδ but not Polε was
shown to proofread errors made by Polα (74) and participate in maturation of Okazaki
fragments on the lagging strand (54,75). At the same time, Polε but not Polδ interacts
with the CMG helicase on the leading strand (7). While the roles of Polδ in synthesis of
the leading strand near replication origins and termination zones have recently been
detected (76-79), these stretches of Polδ synthesis appear to account for a relatively
minor fraction of the leading strand [~18%, (79)]. Overall, a bulk of evidence supports the
originally proposed division of labor with Polε and Polδ predominantly replicating
opposite DNA strands.

POLE mutations in cancer
Ultramutation in colorectal and endometrial cancers
Approximately 6-15% of endometrial tumors and .65-3% of colorectal tumors
contain mutations in POLE, the gene encoding the catalytic subunit of Polε in humans
(80-94). While mutations have been recorded across the entire gene, recurrent hotspot
mutations cluster in the region encoding the exonuclease domain of the protein
(61,95,96). These mutations are associated with extremely high tumor mutation burden,
typically >100 mutations per megabase (termed ultramutated). While cases of germline
mutations in POLE have been reported, most of these ultramutated cancers are
sporadic. Patients presenting with ultramutated colon and endometrial tumors are
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typically younger than patients without mutations in POLE (80,83,86,88,97-99). Notably,
these patients also have better progression free survival than patients with wild-type
POLE (80,83,85,87,97,98,100,101).
POLE mutations have been reported in cancer precursors (endometrial
intraepithelial neoplasias, endometrial hyperplasias, and colorectal adenomas),
suggesting these mutations are early events in sporadic tumors (102,103). Furthermore,
POLE mutant tumors are associated with a specific mutation signature with
characteristic CA mutations in a TCT sequence context (71,82,104-106). Mutations in
oncogenes in POLE mutant tumors have also been found to have CA mutations in a
TCT sequence context (93). While the tumors are ultramutated, they are typically
microsatellite stable, distinguishing these from hypermutated MMR-deficient tumors
which contain between 10 and 100 mutations per megabase (90,91).
POLE-mutant endometrial tumors are morphologically heterogeneous and highly
immunogenic (87,107). The high levels of mutagenesis in POLE-mutant tumors leads to
increased numbers of neo-epitopes (103,108). Associations have been shown with high
levels of CD8+ and CD3+ tumor infiltrating lymphocytes (83,86,87,103,108-112). PD-1
expression in T-lymphocytes and PDL-1 expression in the tumors has also been shown,
suggesting these tumors would respond well to immunotherapy (86,108,109,112-114).
Indeed, anti-PD-1 drugs Nivolumab and Pembrolizumab have both been used to treat
patients with POLE-mutant tumors with good outcomes (115,116).

Polε-P286R
The majority of suspected pathogenic POLE mutations result in amino acid
changes in the exonuclease domain of the polymerase, yet the impact of these
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mutations goes far beyond a simple loss of proofreading. This is best illustrated by the
properties of POLE-P286R, which is the most common POLE variant in sporadic tumors
(61,95,96). POLE-P286R has been reported in over 200 tumors to date, predominantly
endometrial and colorectal but also across other tissue types including ovary, urinary
tract, pancreas, breast, prostate, and brain (81,117). Studies in which the mutation was
introduced in model organisms have illuminated some of the genetic, biochemical, and
physical properties of this particular replicative polymerase variant.

Genetic modeling
After the mutation was found in a cohort of colorectal patients at the University of
Nebraska Medical Center, Kane and Shcherbakova engineered the analogous mutation
in S. cerevisiae. The pol2-P301R mutation caused a 150-fold increase in mutation rate
over the wild-type strain (118). This is 50-fold higher than the mutator effect of Polε
proofreading deficiency and also overwhelmingly exceeds the effect of any previously
studied Polε mutation. Furthermore, Polewt/P286R mice are dramatically more cancerprone than mice deficient in Polε proofreading and, in fact, more cancer-prone than any
existing monoallelic animal model (119,120). The attempts to introduce CRISPRmediated P286R mutation into one copy of POLE in MMR-deficient colon cancer cell line
HCT116 or its MMR-proficient derivative resulted in cells that were heterozygous at the
DNA level but produced almost no POLE-P286R transcripts, suggesting that expression
of the mutant allele could be deleterious for this cell line (121). However, colon cancer
cell line HCC2998, which contains the P286R mutation and is one of the most
hypermutated cell lines known, has elevated mutation frequency and increased CA
mutations (122,123). The mechanisms of these uniquely strong mutagenic and
tumorigenic effects of the P286R variant remain to be determined.
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Biochemical and structural properties
While initial hypotheses suggested that POLE mutations impacting the
exonuclease domain inactivated proofreading, purified four-subunit yeast Polε-P301R
retains residual exonuclease activity (28). The N-terminal part of the catalytic subunit of
human Polε-P286R also retains residual exonuclease activity (71). It was recently
reported that the purified yeast variant has an unusually high DNA polymerase activity in
addition to a severe exonuclease defect (28). It extends matched and mismatched
primer termini more efficiently than either wild-type or proofreading-deficient Polε, and
particularly excels at synthesis through secondary structures that normally impede
replicative polymerases (28). Crystallographic studies of Polε-P301R and molecular
dynamics simulations suggested that the arginine side chain protrudes into the opening
of the exonuclease active site, hindering access of the primer terminus to the catalytic
residues (124). It was, therefore, proposed that the robust increase in polymerase
activity is caused by the inability to accommodate the 3’ end in the exonuclease site,
which prompts Polε-P301R to stay in the polymerization mode (28).

Dissertation overview
This dissertation addresses some unanswered questions regarding the interplay
of Polδ and Polε in the prevention of replication errors, and the consequences of the
most common cancer-associated Polε variant, Polε-P286R (Polε-P301R in S.
cerevisiae). While a plethora of evidence supports the one-strand-one-polymerase
model described above, several studies have indicated that Polε and Polδ do not
operate completely independently. Defects in Polδ have stronger impacts on
mutagenesis than analogous defects in Polε. The combination of proofreading defects in
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Polδ and Polε results in a synergistic increase in mutation rate, which suggests the two
polymerases compete to correct the same pool of replication errors. A hypothesis has
been long-entertained that Polδ corrects errors made by Polε, but direct evidence for this
idea was lacking. Previous studies also left uncertainty regarding leading strand
replication by Polε near termination zones. Additionally, it remained unknown how the
newly revealed biochemical properties of the Polε-P301R variant impact the role of Polε
in replication and correction of its errors.
Chapter 3 describes genetic experiments designed to test the hypothesis that
Polδ corrects errors made by Polε, in addition to its own errors. A synergistic increase in
the mutation rate resulted from combining a Polε selectivity defect with a Polδ
proofreading defect. However, only an additive increase in the mutation rate was
observed from the combination of a Polδ selectivity defect and Polε proofreading defect.
These results provide evidence for a model where Polδ can extrinsically proofread errors
made by Polε, whereas Polε cannot proofread errors made by Polδ.
Chapter 4 focuses on how the Polε-P301R variant affects the role of Polε in DNA
replication. By measuring the accumulation of strand-specific replication errors across a
well-defined replicon, these experiments demonstrate that despite greatly increased
polymerase activity, Polε-P301R remains a dedicated leading strand polymerase.
Furthermore, our results reveal for the first time the strong contribution of Polε to leading
strand replication in the vicinity of the termination zone.
Chapter 5 describes a series of genetic experiments designed to evaluate how
the unprecedented mismatch extension capability of Polε-P301R impacts the correction
of its errors by extrinsic correction mechanisms. The results establish that both extrinsic
proofreading by Polδ and correction by MMR are necessary to maintain viability in cells
expressing Polε-P301R. Moreover, extrinsic proofreading of Polε-P301R errors by Polδ
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is extremely efficient, demonstrating the ease with which polymerase exchange occurs
in vivo.
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Chapter 2: Materials and methods
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Plasmids
The plasmid used to construct pol2-M644G mutants was p173, a URA3-based
yeast integrative vector containing a BamHI-BspEI C-terminal fragment of POL2 (125),
in which the pol2-M644G mutation was created by site-directed mutagenesis (46). It was
kindly provided by Youri Pavlov (University of Nebraska Medical Center). YIpJB1, a
URA3-based yeast integrative vector, was used to construct the pol2-4 mutant strains
(52). To construct pol3-D520V and pol3-L612M mutants, we used p170, a URA3-based
integrative plasmid containing an EcoRV-HindIII C-terminal fragment of POL3 (126), in
which the pol3-D520V and pol3-L612M were created by site-directed mutagenesis
(54,127). These p170 derivatives were also provided by Youri Pavlov. To construct
strains with the ura3-29 or ura3-24 reporter, we used derivatives of YIpGL1 to amplify
the ura3-29::LEU2 and ura3-24::LEU2 cassettes (128,129). pBL304 is an episomal
plasmid containing a URA3 marker, and expressing POL3 (130). YIpDK1-pol2-P301R or
YIpCB2 was used to construct the pol2-P301R mutation. YIpDK1-pol2-P301R is a
derivative of YIpJB1 in which the pol2-4 mutation was changed to wild-type and the pol2P301R mutation was introduced, both by site-directed mutagenesis (118). YIpCB2 was
constructed by replacing the URA3 marker in YIpDK1-pol2-P301R with the LYS2
marker. LYS2 was amplified from chromosomal DNA of a W303 derivative (MATa ade21 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1) provided by Duncan Smith (New York
University) using primers 5’-TTTTTTGCCAATTTGGCCTGGCTCACTTGAGGGCTAT-3’
and 5’-TTTTTTTGGCCAAGCAGACTAACGCCAGCTGA-3’. The primers created BglI
and MscI cut sites at each end of the amplified DNA. The PCR fragment was digested
with BglI and MscI and ligated into YIpDK1-pol2-P301R digested with PflMI and MscI to
create YIpCB2.
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Yeast strains
Construction of ura3-29 and ura3-24 reporter strains
The haploid Saccharomyces cerevisiae strains used to study mutagenesis
across the ARS306 replicon (Appendix B) were derived from CG379Δ, which contains a
deletion of chromosomal URA3 (MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2 leu2-3,112
ura3Δ) (131). The CG379Δ n303::ura3-29inv or1 (and or2) as well as CG379Δ
atg22::ura3-29 or1 (and or2) strains were created by Olga Kochenova in the
Shcherbakova laboratory by amplification of a ura3-29::LEU2 cassette using a derivative
of YIpGL1 containing the ura3-29 allele (128,129). The primers were designed such that
the end of the amplified cassette contain homology to the target site on chromosomal
DNA, so that it is inserted into a defined location upon transformation (Figure 2.1).
Another derivative of YIpGL1 containing the ura3-24 allele was used to amplify the ura324::LEU2 cassette in the same manner. The ura3-29 and ura3-24 reporters were
inserted in a total of six different locations (HBN1, BIK1, HIS4, STE50, LSB5, and
ATG22). PCR primers for cassette amplification and insertion at each location are listed
in Table 2.1.

Construction of DNA polymerase mutants
All DNA polymerase mutants were constructed by integration and excision of a
yeast integrative plasmid containing the desired mutation (Figure 2.2).
Saccharomyces cerevisiae strains used to study extrinsic proofreading of Polε
errors by Polδ (Appendix A) are derivatives of E134 (MATα ade5-1 lys2::InsEA14 trp1289 his7-2 leu2-3,112 ura3-52) (132,133) and 1B-D770 (MATa ade5-1 lys2-Tn5-13
trp1-289 his7-2 leu2-3,112 ura3-4) (133). Strains used to study mutagenesis across the
v
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Figure 2.1. Integration of ura3-29 and ura3-24 reporters.
ura3-29::LEU2 and ura3-24::LEU2 cassettes were amplified using primers with homology to
replicon ARS305-ARS306 in chromosome III at the 5’ end and homology to plasmid YIpGL1
containing the reporter cassette at the 3’ end (top). After PCR amplification of the cassette, yeast
strains were transformed with the cassette, allowing the homologous regions to undergo
recombination (middle), inserting the cassette into the defined location (bottom). Gray lines
indicate plasmid DNA, black indicates chromosomal DNA, and red indicates homologous DNA
sequence.
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Table 2.1. Primers for amplification of ura3-29 and ura3-24 reporter cassettes
Integration
Sitea
HBN1

Primer
n306-F
n306-R

BIK1

HIS4

STE50

LSB5

bik1-F
bik1-R
his4-F
his4-R
ste50-F
ste50-R
lsb5-F
lsb5-R

ATG22

atg22-F
atg22-R

Sequenceb
GCCGGTCAAAAGAGGCCTGCTTCAGCAAGGGAT
GAGGCCaaacgacggccagtgccaag
TACGCTGGGAAGTCAGCCTTTAGCTTTTCAGTTA
CCTTGtgtgggaatactcaggtac
GCGCGGACAACTGAAATACGTGGGTCCAGTGGA
CACGaaacgacggccagtgccaag
CTGTTGTCTTCCTGCCGTGGTATCGACTGGTGCA
Ggttaactgtgggaatactcag
GGCATCTTCATCGGCAATAACCAAAACTTCACTT
GGaaacgacggccagtgccaag
CCAGCACAAGTTGCCCAATGTAAGGAGATTGTGT
TTGCgttaactgtgggaatactcag
GGAGGACGGTAAACAGGCCATCAATGAGGGATC
AAACGAaaacgacggccagtgccaag
CATCAATATTGTGCCATTCACGTCCAGATCCGGC
GAAGgttaactgtgggaatactcag
GGATCATCCGCATACAGCTATCACCGAGACGAT
CTTTCGaaacgacggccagtgccaag
CGTGGACGGCTGATAAGAAGACAAGCTCTCTTC
CTCTGgttaactgtgggaatactcag
ATTGTTGAACAAACCAAGAACACACTTATCTGAaa
acgacggccagtgccaag
GAGCTATGGAACTATAAATGATATGAATGAATCG
GTAgttaactgtgggaatactcag

Chromosomal
positionc
73718
73650
68968
68679
66515
66833
63444
63523
61673
62688
56266
56525

ORFs disrupted by insertion of the reporter cassette are indicated
Primer homology to chromosome III is shown in uppercase, and homology to the
plasmid containing the reporter cassette is shown in lowercase.
c
The chromosomal position corresponding to the first nucleotide of the primer is shown
with respect to the left telomere. Chromosomal sequences deleted within each ORF by
insertion of the cassette are as follows: HBN1 (73688-73717), BIK1 (68714-69831),
HIS4 (66553-66797), STE50 (63483-63485), LSB5 (61712-62650), ATG22 (5630356308). The coordinates of replication origins ARS306 and ARS305 are 74458-74677
and 39508-39595, respectively.
a
b
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Figure 2.2. Integration-excision procedure.
A yeast integrative plasmid containing a selectable marker and a truncated gene harboring a
mutation is cut with a restriction enzyme and introduced into cells via transformation. The cut
vector integrates at the corresponding genomic site via homologous recombination (dashed
lines), leaving the entire plasmid backbone in the chromosome. Further selection against the
marker in the plasmid selects for cells which have undergone homologous recombination (dashed
lines) again to excise the backbone of the plasmid.
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replicon are derivatives of the ura3-29 and ura3-24 reporter strains described above
(Appendix B).
The pol2-M644G mutation was introduced by transformation with p173
containing pol2-M644G mutation linearized with BsrGI, followed by selection for the loss
of the plasmid backbone on medium containing 5-fluoroorotic acid (5-FOA). POL3
mutations were introduced by integration-excision of BseRI-linearized p170 with the
D520V mutation and HpaI-linearized p170 with the L612M mutation. The pol2-4 mutation
was introduced into strains by integration-excision of BamHI-linearized YIpJB1 (52). The
pol2-P301R was introduced by integration-excision of BamHI-linearized YIpDK1-pol2P301R.

Deletion of MSH6
The MSH6 gene was deleted by transformation with a PCR-generated DNA
fragment carrying the kanMX marker. The kanMX marker flanked by approximately 300
base pairs of sequence homology to each side of MSH6, was amplified from
chromosomal DNA of yeast strain TM45 (MATα ade5-1 lys2-InsEA14 trp1-289 his7-2
leu2-3,112 ura3-52 can1∆::loxP msh6∆::kanMX) (134). PCR primers used to amplify the
cassette were 5’-AGTCTCCATTTCCAACTAATG-3’ and 5’CACTCAAGAAATGGAAAATAC-3’.

Construction of double mutant strains
Haploid double mutants
Single-mutant pol2-M644G, pol2-4, pol3-D520V, and pol3-L612M haploids were
crossed to make the desired double-heterozygous diploids, which were then sporulated,
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and tetrads were dissected to obtain double-mutant pol2 pol3 haploids. The presence of
pol2 and pol3 mutations was confirmed by Sanger sequencing.
We created double mutant pol2-4 msh6Δ strains by first transforming with BglIIlinearized YIpJB1 such that the pol2-4 mutation was in the truncated, non-expressed
copy. We then deleted MSH6 as described above, and finally used 5-FOA-containing
medium to select for cells that had lost the YIpJB1 plasmid sequence through
recombination and retained the pol2-4 allele to obtain the double-mutant strains.

Diploid double mutants
Diploid strains used to study the synergistic interaction of various mutations with
(Appendix C) were derived from TM30 (same as 1B-D770 but CAN1::Kl.LEU2) and
TM44 (same as E134 but can1Δ::loxP) (134). Crosses of TM30 and TM44 derivatives
produce diploids with a single copy of CAN1 linked to a selectable marker, K. lactis
LEU2. In this system, recessive can1 mutations can be scored on medium lacking
leucine and containing canavanine. The selection for leucine prototrophy discriminates
against cells that acquire resistance to canavanine due to a loss of the entire
CAN1::Kl.LEU2 locus by mitotic recombination, and nearly all Leu+ Canr colonies result
from intragenic mutations in CAN1 (134). msh6Δ::kanMX (msh6Δ), pol2-4, pol2-P301R,
and pol3-D520V mutations were introduced into TM30 and TM44 as described above.
To make diploid strains heterozygous for pol2-P301R and homozygous for
msh6Δ (Figure 2.3), we first transformed TM30 and TM44 with BglII-linearized YIpDK1pol2-P301R to create haploid strains with the pol2-P301R mutation in the truncated,
non-expressed copy of POL2. We then deleted chromosomal MSH6 in both the TM30
YIpDK1-pol2-P301R and TM44 YIpDK1-pol2-P301R strains as described above, and
crossed the haploids. To obtain the heterozygous pol2-P301R mutation in these strains,
we used 5-FOA medium to select for strains that had lost the YIpDK1-pol2-P301R
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Figure 2.3. Creation of POL2/pol2-P301R msh6Δ/msh6Δ strains.
The pol2-P301R mutation was first introduced into one MATa and one MATα strain from a URA3based integrative plasmid so that the mutant allele was in the truncated copy. MSH6 was then
deleted by disruption with the kanMX cassette. Haploids were crossed to make diploids, and cells
that lost the URA3-based plasmid from both POL2 loci and retained the pol2-P301R mutation in
one copy were selected.
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plasmid from both chromosomes, and used Sanger sequencing to identify clones that
maintained the pol2-P301R mutation in one chromosome.
Diploid strains heterozygous for pol2-P301R and pol3-D520V were made by
crossing TM30 containing the pol2-P301R mutation and TM44 containing the pol3D520V mutation. To create double homozygous pol2-P301R/pol3-P301R pol3D520V/pol3-D520V diploid strains containing a plasmid expressing wild-type POL3
(Figure 2.4), we transformed pol2-P301R/POL2 pol3-D520V/POL3 diploids with pBL304
(POL3). The transformants were subjected to sporulation and tetrad dissection, and
haploid pol2-P301R pol3-D520V pBL304 segregants were identified by Sanger
sequencing. The double-mutant segregants of opposite mating type were then crossed
to obtain double-homozygous diploids for analysis of plasmid loss.
Diploid strains heterozygous for pol2-P301R and homozygous for pol3-D520V
were created as follows (Figure 2.5). TM30 was first transformed with BseRI-linearized
p170-pol3-D520V, which placed the mutation in the truncated, non-expressed copy of
POL3. TM30 containing the pol3-D520V mutation (in the non-expressed copy) was then
transformed with SalI-linearized YIpCB2, which placed the pol2-P301R mutation in the
truncated, non-expressed copy of POL2. We then used medium containing αaminoadipic acid to select for cells which had lost YIpCB2 to obtain the pol2-P301R
mutant. To obtain diploids, we crossed this strain to a TM44 derivative which contained
the p170-pol3-D520V plasmid integrated such that the mutation was also in the
truncated, non-expressed copy of POL3. We used 5-FOA medium to select for cells
which had lost the p170-pol3-D520V plasmid from both chromosomes simultaneously,
and the genotype was confirmed by Sanger sequencing.
To construct the pol3-D520V/pol3-D520V msh6Δ/msh6Δ diploids (Figure 2.6),
we first transformed both TM30 and TM44 with a BseRI-linearized p170 plasmid
containing the pol3-D520V mutation, such that the pol3-D520V mutation was in the
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Figure 2.4. Creation of strains for plasmid loss assay.
Individual haploid mutants were crossed to make double-heterozygous diploids. A plasmid
expressing wild-type POL3 was introduced, and the cells were forced to undergo meiosis (only
one possible variant of segregation is shown). Individual double mutant haploids of opposite
mating type containing the wild-type plasmid were then crossed to create double homozygous
diploids, which were used to evaluate loss of the plasmid expressing wild-type POL3.

32

Introduce pol3-D520V mutation

Introduce pol3-D520V mutation

pol3-D520V

URA3

POL3

pol3-D520V

URA3

POL3
POL2

POL2

Introduce pol2P301R mutation

pol3-D520V

URA3

pol2-P301R LYS2

POL3
POL2

Select cells that have
excised LYS2 plasmid

pol3-D520V

URA3

POL3

Cross to
make
diploids

pol2-P301R

pol3-D520V
pol3-D520V

URA3
URA3

POL3
POL3

pol2-P301R
POL2

Select cells that have
excised URA3 plasmid
pol3-D520V
pol3-D520V

pol2-P301R
POL2

33
Figure 2.5. Creation of POL2/pol2-P301R pol3-D520V/pol3-D520V strains.
The pol3-D520V mutation was first introduced (from a URA3-based integrative plasmid) into
strains of opposite mating type such that the mutation was in the truncated copy of POL3. In one
strain, the pol2-P301R mutant allele was then introduced (from a LYS2-based integrative
plasmid) such that the mutant allele was in the truncated copy of POL2. Cells that lost the LYS2based plasmid and retained the pol2-P301R mutation in the genome were selected and crossed
to cells of opposite mating type containing the pol3-D520V mutation in the truncated copy. Cells
that lost the URA3-based plasmid and retained the pol3-D520V mutation in both chromosomes
were selected.
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Figure 2.6. Creation of pol3-D520V/pol3-D520V msh6Δ/msh6Δ strains.
The pol3-D520V mutant allele was first introduced into haploid strains using a URA3-based
integrative plasmid so that the mutation was in the truncated copy of POL3. Then, MSH6 was
disrupted with a kanMX cassette. The strains were crossed to obtain diploids, and cells that lost
the URA3-based plasmid and retained the pol3-D520V mutation in both chromosomes were
selected.
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truncated, non-expressed portion of POL3. Then we deleted chromosomal MSH6 in
these strains as described above, and crossed to obtain diploids. Finally, we selected for
cells which had lost the p170 plasmid from both chromosomes simultaneously on
medium containing 5-FOA, and used Sanger sequencing to find clones homozygous for
the pol3-D520V mutation, now present in the full-length, expressed alleles. Isogenic
single-mutant diploids (pol3-D520V/pol3-D520V or msh6Δ/msh6Δ) and wild-type
controls were constructed similarly, omitting the MSH6 disruption step, the p170-pol3D520V transformation step, or both.

Mutation rate measurements
The rate of ura3-29 reversion, ura3-24 reversion, CAN1 forward mutation, and
his7-2 reversion in haploids was measured by fluctuation analysis as described
previously (135). ura3-29 and ura3-24 reversion score single point mutations in a TCT
sequence context, CAN1 scores a variety of base substitutions, insertions, and deletions
in many sequence contexts, and his7-2 scores +1 frameshift mutations in an A7 run
(58,128,133,136). For each strain, nine single colonies were inoculated separately into
rich yeast extract peptone dextrose liquid medium supplemented with uracil and adenine
(YPDAU) (135), and the cultures were grown to saturation overnight. The cultures were
appropriately diluted and plated on synthetic complete (SC) medium or selective
medium. SC medium lacking uracil or histidine was used as selective medium for Ura+
and His+ reversion measurements. For Ura+ reversion, the cells were washed with sterile
H2O before dilution. SC medium containing 0.006% L-canavanine and lacking arginine
was used for CAN1 mutation measurements in haploids, whereas SC medium
containing 0.006% L-canavanine and lacking both arginine and leucine was used for
CAN1 mutation measurements in diploids generated from crossing derivatives of TM30
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and TM44. Mutation frequency was calculated by dividing the number of mutant cells in
a culture by the total number of cells in that culture. The mutation rate was derived from
the calculated mutation frequency using the Drake equation (137). Medians and 95%
confidence intervals (138) are reported, and comparison between mutation rates of
different strains was done using the Wilcoxon-Mann-Whitney test.

In vitro error specificity assay
DNA substrates and proteins
Substrates for primer extension assays were prepared by annealing primer P1
(5’-Cy5-ATTTGACTGTATTACCAATGTCAGCAAATTTTCTGTCTTCGAAGAGTAAA) to
template BT1 (5’-BioAAGGCATTATCCGCCAAGTACAATTCTTTACTCTTCGAAGACAGAAAATTTGCTGAC
ATTGGTAATACAGTCAAATTGCAGTACTCTGCGGGTGTATACAG-Bio) and primer P2
(5’-Cy5-CATGGAGGGCACAGTTAAGCCGCTAAAGGCATTATCCGCCAAGTACAATT)
to template BT2 (5’-BioAAATTTTCTGTCTTCGAAGAGTAAAGAATTGTACTTGGCGGATAATGCCTTTAGCGG
CTTAACTGTGCCCTCCATGGAAAAATCAGTCAAGATATCCACAT-Bio). Primer and
template were combined in a ratio of 1:1.5 in the presence of 150 mM NaAc and 20mM
Hepes (pH 7.8), and annealed by incubating the mixture at 95˚C for 3 min and then
cooling to room temperature slowly over approximately 2 h. Streptavidin (NEB #N7021S)
was added in 2-fold molar excess for 10 min at room temperature to block the ends of
the substrate and allow stable loading of the clamp Proliferating Cell Nuclear Antigen
(PCNA) by the clamp loader Replication Factor C (RFC).
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Preparations of four-subunit Polε (exo- and P301R) and PCNA used in this work
have been described (28,134). Purified yeast RFC was kindly provided by Peter Burgers
(Washington University School of Medicine).

Primer extension assay
The 10-μl primer extension reaction contained 40 mM Tris-HCl pH 7.8, 1 mM
dithiothreitol, 0.2 mg/ml bovine serum albumin, 8 mM MgAc2, 125 mM NaAc, 25 nM DNA
substrate, 1 mM ATP, 20 nM RFC, 60 nM PCNA, 6.25 nM Polε and the indicated dNTP.
We used dNTP concentrations equivalent to those measured for wild-type yeast strains
to mimic intracellular conditions (30 μM dCTP, 80 μM dTTP, 38 μM dATP, and 26 μM
dGTP) (134). PCNA was first loaded onto templates by RFC for 5 min at 30˚C before the
addition of Polε. The synthesis reactions were carried out for 5 min at 30˚C and stopped
by the addition of an equal volume of 2x loading buffer containing 95% formamide, 100
mM EDTA and 0.025% Orange G. Samples were boiled for 5 minutes, cooled on ice for
5 min, and 6 μl of each sample was separated by electrophoresis in a 10% denaturing
polyacrylamide gel containing 8 M urea in 1x TBE. Quantification of fluorescent products
was carried out on a Typhoon imaging system (GE Healthcare). Averages of three
separate runs were compared using an unpaired t-test.

Determination of ura3-29 reversion specificity
Single colonies of ura3-29 strains containing either the pol2-4 or pol2-P301R
mutation were inoculated into YPDAU and the cultures were grown to stationary phase
overnight. The cultures were washed in sterile H2O, diluted and plated on SC medium
lacking uracil. The plates were incubated for 5 days at 30˚C and a single Ura+ revertant
colony from each culture was randomly picked for DNA isolation. A fragment including
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122 nucleotides upstream of URA3 and nucleotides 1-721 of the URA3 open reading
frame was amplified using primers 5’-GGAAGGAGCACAGACTTAGATT-3’ and 5’CCTTTGCAAATAGTCCTCTTCC-3'. The products were purified and Sanger sequencing
was done with primer 5’-GTTAGTTGAAGCATTAGGTCC-3’.

Plasmid loss assay
To determine whether yeast strains could survive without a plasmid expressing
wild-type POL3, diploid strains harboring pBL304 were grown in YPDAU to saturation
and then serially diluted in a sterile 96-well plate. A 48-pronged replicator was used to
transfer diluted cultures to SC medium, or medium containing 5-FOA to select against
the pBL304 plasmid. The ability to survive without wild-type POL3 was determined by
comparing growth on SC versus growth on 5-FOA medium.
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Chapter 3: Extrinsic proofreading of Polε errors by Polδ
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Introduction and rationale
As described in Chapter 1, the most widely-accepted model for eukaryotic DNA
replication suggests that Polα-primase synthesizes short RNA-DNA primers at
replication origins and the beginning of Okazaki fragments on the lagging strand, Polε
synthesizes the leading strand and Polδ synthesizes the lagging strand. An abundance
of evidence from genetic and biochemical studies supports this model. In contradiction to
this model, however, Polδ fidelity defects have long been known to have a greater
impact on mutagenesis than analogous Polε defects. The mutator phenotype resulting
from pol3-01, which encodes proofreading-deficient Polδ (Polδ-exo-), is an order of
magnitude stronger than the phenotype of the analogous pol2-4 mutation, which
encodes proofreading-deficient Polε (Polε-exo-) (52,53,58,59,130-132,139-141).
Furthermore, haploid yeast deficient in Polδ proofreading do not survive when MMR is
also inactivated, with the death attributed to an excessive level of mutagenesis (142). In
contrast, yeast lacking both proofreading by Polε and MMR are viable, and while the
mutation rate in these strains is high, it does not reach the lethal threshold
(29,59,130,132,141). Similarly, when identical tyrosine to alanine substitutions were
made in the conserved region III of the polymerase domains (Polδ-Y708A and PolεY831A), the Polδ variant produced a much stronger mutator effect than the analogous
Polε variant (143). To explain the controversy between the accepted fork model and the
disparity of Polδ and Polε effects on mutagenesis, a hypothesis has been entertained
that Polδ proofreads errors made by Polε in addition to its own errors, thus contributing
more significantly to mutation avoidance. This hypothesis, discussed in multiple
publications (58,144-146), stems from the original observation by Morrison and Sugino
that the combination of Polδ and Polε proofreading defects results in a synergistic
increase in mutation rate (130). The synergy implies that the exonucleases of Polε and
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Polδ act on the same pool of replication errors and could potentially mean Polε
correcting errors made by Polδ, Polδ correcting errors made by Polε, or both
polymerases proofreading for each other.
In general, the possibility of extrinsic proofreading has been demonstrated in
multiple in vivo and in vitro studies. Initial experiments showed that errors made by
purified calf thymus Polα could be corrected by the ε subunit of E. coli DNA polymerase
III or by Polδ (147,148). Several mammalian autonomous exonucleases have also been
shown to increase the fidelity of Polα in vitro (149-151). Both E. coli and eukaryotic
replicative polymerases can excise nucleotides incorporated by translesion synthesis
polymerases at sites of DNA damage (152,153). In respect to the extrinsic proofreading
capabilities of Polδ and Polε in vivo, several studies have been illuminating. Polδ but not
Polε has been shown to proofread errors made by an error-prone Polα variant in yeast
(74). Further, Polδ exonuclease defects are almost completely recessive indicating that
wild-type Polδ can efficiently proofread errors created by Polδ-exo- (53,142,146). On the
other hand, the mutant allele encoding Polε-exo- is semidominant, suggesting that wildtype Polε does not correct errors in trans (118,146). Experiments employing
transformation of yeast cells with oligonucleotides that, when annealed, create a 3’terminal mismatch also showed that Polδ but not Polε can proofread in trans (146).
These experiments further showed that the exonuclease of Polδ can act on
oligonucleotides annealed to both leading and lagging strands (146). However, it
remained unknown whether the exonuclease of Polδ could proofread errors generated
by Polε during normal chromosomal replication.
To answer this question, we used yeast strains harboring a nucleotide selectivity
defect in one polymerase, Polδ or Polε, and a proofreading defect in the other. We
compared mutation rates between the corresponding single and double mutants to
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determine whether the proofreading activity of one polymerase acts in series or in
parallel with the nucleotide selectivity of the other. The results show that Polδ can
correct errors made by Polε, but Polε cannot correct errors made by Polδ. This
observation provides direct evidence that the remarkably mild in vivo consequences of
severe Polε fidelity defects are explained by the compensatory proofreading by Polδ.
These findings support a replication fork model wherein synthesis on leading and
lagging strands is primarily accomplished by separate polymerases, but proofreading is
more dynamic and can be performed by the exonuclease of Polδ on both strands.

The pol3-D520V mutation as a tool to study Polδ proofreading
The synergistic interaction between the exonucleases of Polε and Polδ has been
previously demonstrated using the pol2-4 and pol3-01 alleles, which result in the
replacement of two catalytic carboxylates in the Exo I motif of the respective polymerase
with alanines (FDIET/CFAIAT/C; (130)). The pol3-01 mutation, however, may have
consequences beyond simply destroying the exonuclease of Polδ, as its extremely
strong mutator phenotype has been reported to be partially dependent on the activation
of S-phase checkpoint (154), and a different allele, pol3-D520V, exists that also
eliminates the exonuclease activity but is a weaker mutator (54). We started by verifying
that the synergy between Polε and Polδ could still be detected when the pol3-D520V
allele is used instead of pol3-01 to produce exonuclease-deficient Polδ. While the pol2-4
pol3-01 double mutant haploids were inviable due to a catastrophically high mutation
rate (130), the pol2-4 pol3-D520V haploids survived (Figure 3.1). The mutation rate in
the pol2-4 pol3-D520V strains increased synergistically as compared with the single
pol2-4 and pol3-D520V mutants (Table 3.1), consistent with the idea that the
exonucleases of Polδ and Polε act on same pool of replication errors. We next
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pol2-4 x pol3-D520V

Figure 3.1. pol2-4 pol3-D520V haploid yeast are viable.
Tetrad analysis of yeast strains heterozygous for the pol3-D520V and pol2-4 alleles, encoding
exonuclease-deficient Polδ and Polε, respectively. Red circles indicate double mutant haploid
spores.
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Table 3.1. Synergistic interaction of pol2-4 and pol3-D520V
Genotype

CAN1 mutation
Mutation rate
Fold
(x10-7)
increase

his7-2 reversion
Mutation rate
Fold
(x10-8)
increase

POL2 POL3

2.5

(2.1-2.9)

1

0.83

(0.70-0.97)

1

pol2-4 POL3

7.6

(6.8-8.7)

3.0

6.3

(5.6-6.9)

7.6

(16-21)

7.6

8.0

(7.0-9.6)

9.6

POL2 pol3-D520V

19

pol2-4 pol3-D520V

200

(130-260)

80

100

(61-290)

120

Mutation rates are medians for at least 18 cultures from two to three independently constructed
strains of the same genotype. 95% confidence intervals are shown in parentheses.
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ascertained that this synergistic interaction is not due to the pol3-D520V mutation
disrupting MMR. If the exonuclease of Polδ is essential for functional MMR, combining
pol3-D520V with a MMR defect would yield no further increase in mutation rate beyond
the effect of pol3-D520V alone. On the other hand, if Polδ proofreading and MMR act in
series, a synergistic increase in mutation rate would be expected in the double mutants.
Haploid yeast deficient in MMR and harboring pol3-D520V are not viable (57); therefore,
we assessed the epistatic relationship between pol3-D520V and MMR deficiency in
diploid strains, which can tolerate a higher level of mutagenesis. We used the MSH6
deletion to inactivate MMR, as the Msh6-dependent pathway is primarily responsible for
the repair of single-base mismatches (155), which is the predominant type of replication
errors generated by exonuclease-deficient Polδ and Polε (28,49,50). Diploids
homozygous for both pol3-D520V and msh6Δ mutations showed a strong synergistic
increase in mutation rate as compared with the single pol3-D520V and msh6Δ mutants
(Table 3.2). Similar synergistic increase in mutagenesis in pol3-D520V/pol3-D520V
msh6Δ/msh6Δ diploids was observed in an earlier study that scored base substitutions
at a single nucleotide position in the TRP5 gene (146). We recapitulate and expand
these earlier findings by using the forward mutagenesis reporter, CAN1, that can detect
a variety of base substitutions and indels in many DNA sequence contexts, as well as
the his7-2 frameshift reporter that is particularly sensitive to MMR defects. Together,
these data demonstrate that pol3-D520V does not confer a MMR defect. Thus, the
synergy between pol2-4 and pol3-D520V indicates proofreading of the same errors by
Polε and Polδ. It also shows that pol3-D520V allele provides an adequate model for the
extrinsic proofreading studies described below.
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Table 3.2. Synergistic interaction of pol3-D520V and MMR deficiency
Genotype
POL3/POL3
MSH6/MSH6

CAN1 mutation
Mutation rate (x10-7)
Fold increase
3.4

(3.0-4.0)

1

POL3/POL3
msh6Δ/msh6Δ

31

(28-36)

9.1

pol3-D520V/pol3-D520V
MSH6/MSH6

46

(35-69)

14

pol3-D520V/pol3-D520V
msh6Δ/msh6Δ

4400

(3100-6000)

1300

Mutation rates are medians for at least 18 cultures from two to
three independently constructed strains of the same genotype.
95% confidence intervals are shown in parentheses.
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Interplay of Polε and Polδ in replication error avoidance
Polδ proofreads errors made by Polε
Next, we investigated whether Polδ proofreads errors made by Polε by
combining a nucleotide selectivity defect in Polε (pol2-M644G) with a proofreading
defect in Polδ (pol3-D520V). The pol2-M644G confers a change in the polymerase
domain of Polε, which causes promiscuity during nucleotide incorporation without
compromising proofreading (46). The pol2-M644G strains, therefore, accumulate a high
number of Polε-specific errors. We observed a synergistic increase in mutation rate in
the double pol2-M644G pol3-D520V mutants (Table 3.3). This synergy indicates that the
nucleotide selectivity of Polε and the proofreading activity of Polδ act consecutively to
prevent replication errors and, thus, Polδ proofreads errors made by Polε in vivo.

Polε does not proofread errors made by Polδ
In a reciprocal experiment, we combined a Polδ nucleotide selectivity defect
(pol3-L612M) with a Polε proofreading defect (pol2-4) to determine whether Polε can
proofread errors made by Polδ. Similar to pol2-M644G, pol3-L612M increases the rate of
nucleotide misincorporation by Polδ without impacting exonuclease activity (45). In
contrast to the pol2-M644G pol3-D520V combination, the pol3-L612M pol2-4
combination resulted in only an additive increase in the mutation rate in the double
mutant compared to the single pol3-L612M and pol2-4 mutants (Table 3.4). The additive
interaction indicates that Polδ nucleotide selectivity and Polε exonuclease activity act in
parallel, non-overlapping pathways, and, therefore, Polε does not proofread errors made
by Polδ.

48

Table 3.3. Synergistic interaction of Polε nucleotide selectivity and Polδ
proofreading defects
CAN1 mutation

his7-2 reversion

Genotype

Mutation rate
(x10-7)

POL2 POL3

2.5

(2.1-2.9)

1.0

0.83

(0.70-0.97)

1.0

pol2-M644G POL3

9.7

(8.2-12)

3.9

1.4

(1.0-1.6)

1.7

7.6

8.0

(7.0-9.6)

9.6

POL2 pol3-D520V

19

(16-21)

pol2-M644G pol3-D520V

92

(77-110)

Fold
increase

37

Mutation rate
(x10-8)

13

(11-15)

Fold
increase

16

Mutation rates are medians for at least 18 cultures from two to three independently constructed
strains of the same genotype. 95% confidence intervals are shown in parentheses.
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Table 3.4. Additive interaction of Polδ nucleotide selectivity and Polε proofreading
defects
CAN1 mutation

his7-2 reversion

Genotype

Mutation rate
(x10-7)

POL2 POL3

2.5

(2.1-2.9)

1.0

0.83

(0.70-0.97)

1.0

pol2-4 POL3

7.6

(6.8-8.7)

3.0

6.3

(5.6-6.9)

7.6
6.0

Fold
increase

Mutation rate
(x10-8)

POL2 pol3-L612M

11

(9.7-13)

4.4

5.0

(4.1-5.9)

pol2-4 pol3-L612M

17

(16-18)

6.8

8.9

(7.6-11)

Fold
increase

11

Mutation rates are medians for at least 18 cultures from two to three independently constructed
strains of the same genotype. 95% confidence intervals are shown in parentheses.
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Discussion
The accepted model for eukaryotic DNA replication is not easily reconciled with
the stronger mutator effects of Polδ variants in comparison with analogous Polε variants.
It has been proposed that Polδ can proofread errors made by Polε in addition to its own
errors, which would explain its more prominent contribution to mutation avoidance.
Currently available data suggest that, indeed, Polδ but not Polε can readily proofread
errors in trans (53,74,118,142,146). However, evidence that Polδ can specifically
proofread DNA synthesized by Polε at the replication fork has been lacking. Using
inaccurate variants of Polδ and Polε, here we demonstrate that incorrect nucleotides
incorporated by Polε are efficiently removed by the exonuclease of Polδ but Polε cannot
remove nucleotides misincorporated by Polδ (Figure 3.2). This conclusion is supported
by two observations. (i) The mutation rate increases synergistically when the Polε
nucleotide selectivity defect is combined with Polδ proofreading defect. (ii) Only an
additive increase in mutagenesis is observed when Polδ nucleotide selectivity defect is
combined with Polε proofreading defect.
Multiple studies suggested that Polδ is more efficient at extrinsic proofreading
than Polε. Polδ can remove mismatches generated by Polα both in vitro and in vivo
(74,148). Since Okazaki fragments are all initiated by exonuclease-deficient Polα, there
is a clear need for extrinsic proofreading by the lagging strand polymerase, whereas
there is less of a need for Polε to carry this out on the leading strand. Indeed, Polε does
not appear to correct errors made by Polα in vivo (74). It is particularly interesting to note
the recent evidence that initial leading strand synthesis is performed by Polδ (76-78),
which further diminishes the need for extrinsic proofreading of Polα-generated errors by
Polε on the leading strand. Additionally, the semidominance of the pol2-4 mutation and
almost complete dominance of POL3 over the pol3-01 and pol3-D520V mutations
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Polε
exo

Intrinsic and extrinsic
proofreading

exo

Intrinsic
Proofreading*

Polδ

Figure 3.2. Interplay of Polε and Polδ proofreading and synthesis activities at the
replication fork.
Polε replicates the leading strand and proofreads its own errors. Polδ replicates the lagging
strand but can remove errors made by Polε in addition to its own errors.
*The intrinsic and extrinsic proofreading shown in the model relates specifically to the interplay
between Polε and Polδ. There also exists evidence to suggest Polδ can carry out extrinsic
proofreading of Polα and Polδ errors on the lagging strand as well.
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demonstrates that only Polδ can remove errors inserted by a different polymerase
molecule (53,118,142,146). The removal of 3’ terminal mismatches during
oligonucleotide-mediated transformation by Polδ but not Polε (146) also suggests that
Polδ is much better suited to extrinsic proofreading than Polε. Finally, this study provides
evidence that Polδ proofreads errors made by Polε in vivo, while Polε cannot proofread
for Polδ.
Thus, the competition of Polδ and Polε exonucleases for correcting the same
pool of replication errors originally demonstrated by Morrison and Sugino in the 1990s
(130) is apparently one-sided. Perhaps the different properties and regulatory
mechanisms of the two polymerases leave them appropriately suited to their own
specialized roles. Polε is a component of the replication initiation complex, where it
associates with origins during the G1/S phase transition (156,157). Polε remains bound
to the moving helicase via the C-terminus of its catalytic subunit, Pol2, as the N-terminus
copies the leading strand (7,46). A flexible region between the two halves of Pol2 could
allow the polymerase to dissociate from the DNA while remaining bound to the
replication machinery upon dissociation of accessory subunits (18,19). This association
with the helicase indicates that Polε may not be free to carry out extrinsic proofreading,
but the flexibility of the N-terminus could allow a different polymerase access to the 3’end of the leading strand. On the other hand, dissociation and re-association of Polδ
with the primer terminus occurs routinely during lagging strand synthesis, and Polδ is
loaded much faster than Polε onto PCNA-primer-template junction (158). Thus, the high
efficiency of Polδ at correcting errors made by Polε may result from a combination of two
factors: the high proclivity of Polε to yield to another polymerase, and the greater
flexibility and robustness of Polδ when associating with new primer termini.
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Chapter 4: Strand specificity of Polε-P301R errors
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Introduction and rationale
As described in Chapter 1, the mutation conferring P286R substitution in human
POLE is the most common POLE mutation observed in cancers (61,95,96). Initial
genetic analysis in yeast demonstrated a strong increase in mutation rate for cells with
the pol2-P301R mutation (118). Recent structural and biochemical analysis of the
purified yeast variant Polε-P301R indicated that the arginine substitution blocks the
primer terminus from accessing the exonuclease active site, increasing polymerase
activity (28,124). The model proposed by these studies suggested that the increased
polymerase activity causes a strong propensity to extend from mismatches, leading to
the high mutation rate in these strains. The experiments described in this chapter were
designed to test if the increased polymerase activity affected whether Polε-P301R
replicated the leading strand. A genetic system was designed to measure strand-specific
mutation accumulation across a well-defined replicon in yeast, and the results presented
in this chapter demonstrate that Polε-P301R is strictly a leading strand replicase.

A genetic system to study strand-specific replication errors
The contribution of error-prone Polε variants to DNA replication can be monitored
by measuring their mutator effects at various locations within replicons. Replication
origins and termination zones are well-defined in Saccharomyces cerevisiae (12).
Autonomous replicating sequence 306 (ARS306) and ARS305 are two adjacent earlyfiring replication origins, and termination of replication consistently occurs at the midpoint
between these two origins (12). We developed a genetic system to study the effects of
the pol2-P301R allele encoding Polε-P301R and pol2-4 allele encoding Polε-exo- on
mutagenesis at different positions within this replicon. This system comprises a series of
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strains with a reversion reporter allele, ura3-29, at six locations between ARS306 and
the termination zone (Figure 4.1a). The ura3-29 strains can revert to a Ura+ phenotype
via CT, CA, or CG substitutions in a TCT sequence context (Figure 4.1b, left)
(58,143). We placed the reporter allele in two orientations at each location within the
replicon, such that the TCT sequence was either in the leading strand or the lagging
strand (Figure 4.1b, right), producing a total of 12 reporter strains.
The ura3-29 reporter is particularly well suited to characterize Polε-P301R- and
Polε-exo--induced mutagenesis as both Polε variants predominantly generate CT
transitions and CA transversions (28,159), in line with the mutational specificity of
POLE mutant tumors (71,82,106). Sequencing of Ura+ revertants arising in the pol2P301R and pol2-4 derivatives of our reporter strains confirmed that reversion occurs via
CT transitions and CA transversions, and CG transversions are extremely rare
(Figure 4.2 and Table 4.1). Both CT and CA were observed at comparable
frequencies regardless of the orientation of the reporter allele.
Next, we examined whether our system could distinguish between leading and
lagging strand errors. A CT transition can occur via mispairing an incoming dATP with
template C, or dTTP with template G during copying of the opposite strand. Similarly, a
CA transversion can result from a dTTP mispairing with template C, or dATP with
template G in the opposite strand. CT and CA mutations observed in vivo could be
ascribed to either leading or lagging strand errors if there is a bias in the formation of
reciprocal mispairs, as described previously (45,160). To compare the frequency at
which Polε-exo- and Polε-P301R generate reciprocal mispairs at the ura3-29 mutation
site, we studied the incorporation of correct and incorrect nucleotides by purified
polymerases in vitro on templates mimicking the ura3-29 sequence. We used two
oligonucleotide substrates containing either transcribed or non-transcribed strand of the
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A

ARS306

Termination zone
ARS305
midpoint
Chromosome III

74000

71000

68000

65000

62000

59000

56000

Location of reporter

B
Ura-

Ura+

C in leading strand template

TCT

ura3-29

TTT
TCT

TGT

ura3-29

TAT

C in lagging strand template

C
Ura-

Ura+

TCT

TTT

TCT

C in leading strand template
TCT
ura3-24

ura3-24
TCT
C in lagging strand template

Figure 4.1. A genetic system for analysis of mutagenesis across a replicon.
A. A reversion reporter was placed at six locations between ARS306 and the nearest replication
termination zone. Grey numbers show nucleotide position with respect to the left telomere on
chromosome III.
B. ura3-29 strains cannot grow on medium lacking uracil and revert to a Ura+ phenotype via
CT, CA or CG mutations in a TCT context (58,143). The ura3-29 reporter was inserted in
two orientations at each location shown in (A), placing the TCT sequence in either the leading or
the lagging strand template.
C. ura3-24 strains cannot grow on medium lacking uracil and revert to Ura+ phenotype via CT
transitions in a TCT sequence context. This is the same sequence context as in ura3-29 but
positioned in the opposite strand in respect to the direction of transcription (58). The ura3-24
reporter was also placed in two orientations at each location shown in (A).
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n=59

n=84

1.0

Proportion of
reversion events

Proportion of
reversion events

1.0
0.8
0.6
0.4
0.2
0.0

pol2-4
1

C in leading
strand template

CT

CA

n=113

pol2-4
3

pol2-P301R
4

0.8
0.6
0.4
0.2
0.0

pol2-P301R
2

n=131

CG

C in lagging
strand template

Figure 4.2. Reversion specificity of ura3-29 in pol2-mutant strains.
ura3-29 reverts primarily via CT transitions and CA transversions in pol2-4 and pol2-P301R
strains. The results shown are based on sequencing 3 to 34 independent revertants for each
location and orientation of the ura3-29 allele; data for the six locations are combined. Data for
individual strains are shown in Table 4.1.
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Table 4.1. ura3-29 reversion specificity.

Reporter
position
hbn1
hbn1
bik1
bik1
his4
his4
ste50
ste50
lsb5
lsb5
atg22
atg22

C in leading
or lagging
strand
leading
lagging
leading
lagging
leading
lagging
leading
lagging
leading
lagging
leading
lagging

pol2-4

pol2-P301R

CT

CA

CG

CT

CA

CG

8
8
10
0
0
12
7
2
0
10
12
25

4
8
6
3
5
0
2
5
0
6
4
5

1
0
0
0
0
0
0
0
0
0
0
0

5
10
5
0
9
6
18
1
10
10
20
10

14
16
4
11
9
2
16
4
17
17
4
9

0
1
0
0
0
1
0
0
0
0
0
0

Number of reversions of each type observed at each position of the ura3-29 reporter.
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ura3-29 as a template (template G or template C, respectively; Figure 4.3a). The
templates contained streptavidin bumpers on each end to allow stable loading of PCNA
by RFC. Primers were positioned such that the first nucleotide incorporated would be at
the site of the ura3-29 mutation. Both Polε variants generated transition- and
transversion-type mispairs significantly more efficiently when C was the templating base
(Figure 4.3b,c). This strong bias allowed us to use the ura3-29 reporter to determine the
rate of strand-specific errors in cells harboring Polε-exo- and Polε-P301R.

Strand specificity of Polε-P301R
In haploid pol2-4 strains containing Polε-exo-, the rate of Ura+ reversion was
consistently higher for the orientation of ura3-29 that scores leading strand errors
(Figure 4.4a). The bias persisted across the entire replicon and disappeared abruptly at
the termination zone. To confirm that the bias was not due to the differences in the
direction of transcription relative to DNA replication between the two orientations of ura329, we used a second set of strains containing a different reporter allele, ura3-24, placed
in the same six chromosomal locations (Figure 4.1c). The ura3-24 strains revert to a
Ura+ phenotype via CT substitutions in the same TCT sequence context but the TCT
sequence is in the transcribed DNA strand in the ura3-24 while it is in the nontranscribed strand in ura3-29 (compare Figure 4.1b and c). The rates of ura3-24
reversion in pol2-4 strains were still higher when C was in the leading strand, confirming
that the bias was due to replication and not transcription asymmetry (Figure 4.5a). We
also verified that the bias was not due to the differential MMR activity on the two strands
as it was also observed, even to a greater extent, in pol2-4 msh6 strains lacking Msh6dependent MMR (Figure 4.5b). Neither ura3-29 nor ura3-24 reversion showed a bias in
strains with wild-type Polε (Figure 4.6). These results are consistent with the replication
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Figure 4.3. A bias in the formation of reciprocal mispairs at the ura3-29 mutation site.
A. Oligonucleotide substrates for primer extension assays. The DNA sequence of the substrates
corresponds to the sequence context of the ura3-29 mutation. Sequences of the non-transcribed
and transcribed strands serve as templates in the top and bottom substrates, respectively. The
mutation site is indicated. Streptavidin bumpers are shown as grey circles.
B. Primer extension by Polε-exo- and Polε-P301R on substrates described in (A). Reactions were
carried out for 5 min using a 4:1 ratio of substrate to polymerase, and the products were
separated by denaturing polyacrylamide gel electrophoresis. The dNTPs present in each reaction
are indicated below the gel image.
C. The efficiency of nucleotide misincorporation by Polε-exo- and Polε-P301R at the ura3-29
mutation site. Percent misincorporation was calculated by dividing the fraction of primer extended
with an incorrect nucleotide by the fraction of primer extended with the correct nucleotide. Data
are averages of three experiments. Error bars represent standard deviation. Asterisks indicate
p<0.05 by t-test.
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Figure 4.4. Polε-P301R, like Polε-exo-, is a dedicated leading strand polymerase.
The rate of Ura+ reversion in pol2-4 (A) and pol2-P301R (B) strains with the different locations of
ura3-29 reporter shows the bias toward errors at leading strand cytosines. Data are medians for
at least 18 cultures from two to six independent clones. Error bars represent 95% confidence
intervals and asterisks indicate p<0.05 by Wilcoxon-Mann-Whitney test.
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Figure 4.5. The higher mutability of leading strand cytosines in pol2-4 strains is observed
regardless of their position in the transcribed vs. non-transcribed strand, and regardless
of MMR activity.
The rate of Ura+ reversion in pol2-4 (A) and pol2-4 msh6Δ::kanMX (B) strains with the different
locations of ura3-24 reporter shows the bias toward errors at leading strand cytosines. Data are
medians for at least 18 cultures from two to six independent clones. Error bars represent 95%
confidence intervals and asterisks indicate p<0.05 by Wilcoxon-Mann-Whitney test.
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Figure 2.6. The rate of Ura+ reversion in wild-type (POL2+) strains is similar for the two
orientations of ura3-29 or ura3-24 alleles.
Data are medians for at least 18 cultures from two to six independent clones. Error bars represent
95% confidence intervals and asterisks indicate p<0.05 by Wilcoxon-Mann-Whitney test.
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fork model wherein Polε synthesizes the leading strand. We observed a similar pattern
of mutagenesis in pol2-P301R strains harboring the cancer-associated variant PolεP301R (Figure 4.4b). The reversion rates were up to 17 times higher when C was in the
leading strand, and the bias disappeared at the termination zone. The only major
difference between pol2-4 and pol2-P301R strains was in the absolute rate of leading
strand errors, which was an order-of-magnitude higher for pol2-P301R across the entire
replicon. We conclude that, despite the dramatic change in the biochemical properties
(28), Polε-P301R remains a strict leading strand polymerase.

Discussion
The most common cancer-associated Polε variant, Polε-P286R, has elevated
DNA polymerase activity and causes an exceptionally strong mutator effect and tumor
susceptibility when modeled in yeast or mice (28,118,120). Here we used the yeast
model to assess the impact of this variant on the strand-specificity of Polε in DNA
replication. The results presented in this chapter demonstrate that, despite the dramatic
change in biochemical properties, Polε-P301R remains a dedicated leading strand
replicase.
The assay for the detection of leading and lagging strand errors developed in this
chapter provided new information on the mechanism of DNA replication in S. cerevisiae.
The currently accepted fork model, originally proposed by the Sugino group (14), posits
that Polε and Polδ synthesize the bulk of leading and lagging DNA strands, respectively.
The most compelling evidence for this model comes from genetic studies that monitor
strand-specificity of mutation or ribonucleotide incorporation in yeast strains with
reduced fidelity of Polε or Polδ (46,58,69-73). Earlier studies used reporter alleles placed
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in different orientations near a replication origin, and, thus, could deduce the roles of
Polε and Polδ only in the vicinity of the origin [(46,58,69,130); discussed further in (144)].
Subsequent genome-wide studies of mutation and ribonucleotide incorporation in Polε
and Polδ mutants extended the division-of-labor model to multiple replicons (70,72,73).
However, because the genome-wide analysis relied on averaging data for many
replicons where the location of the termination zone can vary, this analysis, too, was
most efficient at assigning the polymerase roles in the vicinity of the origins. The bias for
Polε errors on the leading strand and Polδ errors on the lagging strand was significantly
reduced toward the termination zone (70,72,73). It remained unclear whether the
reduced bias was due to the limitations of the genome-wide analysis or if the forks
rearranged as they moved further away from the origins. The reversion assay used in
our study is more sensitive and allowed us to detect a strong bias in the proximity of the
termination zone (Figure 4.4), demonstrating that the majority of leading strand
synthesis is completed by Polε from origin to termination zone. Recently published data
mapping ribonucleotide incorporation by mutator Polε and Polδ variants revealed less
synthesis by Polε and more synthesis by Polδ at termination zones (≤10 kb from the
termination zone midpoint) than expected from the one-strand-one-polymerase model
(79). Our data shows a strong bias for Polε participation in leading strand synthesis at
10, 8, and 6 kb from the calculated inter-origin midpoint and a loss of bias only at the
very last reporter location (less than 1 kb from the midpoint). A slight decrease in Polε
synthesis in the 10-kb segment, however, may not be detected in our experiments.
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Chapter 5: Extrinsic correction of Polε-P301R errors
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Introduction and rationale
As described in Chapter 1, nucleotide selectivity, proofreading, and MMR act in
series. The results presented in Chapter 3 demonstrated that extrinsic proofreading of
Polε-generated errors by Polδ is an additional proofreading mechanism by which
replication errors are minimized. Because of the hyperactivity and extraordinary
mismatch extension ability of the purified Polε-P301R (28), and the extreme levels of in
vivo mutagenesis (118), we designed experiments to probe the extent of error correction
by MMR and extrinsic proofreading by Polδ in pol2-P301R S. cerevisiae strains. The
results show that MMR and extrinsic proofreading by Polδ are both required to maintain
viability of cells that carry Polε-P301R as the sole source of Polε. Additionally, lack of
Polδ proofreading or MMR in diploid strains heterozygous for the pol2-P301R mutation
leads to near-lethal levels of mutagenesis. We conclude that MMR and Polδ
proofreading efficiently correct Polε-P301R errors to prevent catastrophic accumulation
of leading strand errors in pol2-P301R strains.

Proofreading of Polε-P301R errors by Polδ
Prior studies have shown that Polδ can proofread errors made by Polα and Polε
[(74,161) and Chapter 3]. We aimed to determine if the pol2-P301R mutation, which
greatly increases DNA polymerase activity and mismatch extension ability of Polε,
affects the efficiency of extrinsic proofreading by Polδ. To generate strains deficient in
Polδ proofreading, the chromosomal wild-type POL3 gene encoding the catalytic subunit
of Polδ was replaced with the pol3-D520V allele. As discussed in Chapter 3, the pol3D520V mutation results in D520V substitution in the conserved Exo III motif and a
severe reduction in the exonuclease activity of Polδ (54). A combination of pol3-D520V
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and pol2-4 mutations results in a strong synergistic increase in mutation rate in both
haploid and diploids, as expected from previous studies and consistent with Polδ
proofreading errors made by Polε [(161);Table 3.1; Table 5.1]. Experiments described in
Chapter 3 and reference (161) demonstrated that this synergistic interaction reflects
proofreading of errors made by Polε-exo- by the exonuclease of Polδ, and not the
involvement of the exonuclease of Polδ in MMR as suggested earlier. To study the
genetic interaction of the pol3-D520V mutation with pol2-P301R, we first attempted to
combine the mutations by crossing single pol3-D520V and pol2-P301R mutants and
sporulating heterozygous diploids. This procedure yielded no viable double mutant
spores (Figure 5.1a). The inviable spores formed microcolonies before cell division
stopped (Figure 5.1b). This phenotype is characteristic of a replication error catastrophe
(142). To test this hypothesis, we sought approaches to determine whether the
combination of pol2-P301R and pol3-D520V results in a synergistic increase in the
mutation rate. Diploids can tolerate higher levels of mutagenesis, and mutator effects of
many allele combinations lethal in haploids could be studied in diploids (57,59,130,142).
Diploid yeast homozygous for both pol3-D520V and pol2-P301R also did not survive, as
indicated by their inability to lose an episomal plasmid expressing wild-type POL3
(Figure 5.1c). These observations were consistent with the idea that Polδ exonuclease
is required to keep the level of replication errors in pol2-P301R strains below the lethal
threshold. Indeed, the levels of mutagenesis in diploids homozygous for the pol2-P301R
alone already approach the viability threshold for diploid cells (118,162), and further
increase due to the loss of proofreading by Polδ may be fatal.
To further determine whether Polδ exonuclease activity proofreads Polε-P301R
errors, we created diploid yeast homozygous for pol3-D520V and, thus, lacking Polδ
proofreading, and heterozygous for pol2-P301R. Heterozygosity for pol2-P301R
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Table 5.1. Synergistic interaction of heterozygosity for pol2-4 with Polδ
proofreading deficiency
CAN1 mutation
Genotype

POL2/POL2
POL3/POL3
POL2/POL2
pol3-D520V/pol3-D520V
POL2/pol2-4
POL3/POL3
POL2/pol2-4
pol3-D520V/pol3-D520V

Mutation rate
(x10-7)
3.4 (3.0-4.0)
46 (35-69)
5.5 (4.6-6.6)
130 (100-160)

Fold
increase
1
14
1.6
39

his7-2 reversion
Mutation rate
(x10-8)
1.1 (0.85-1.3)
17 (15-23)
4.5 (3.9-6.1)
70 (58-93)

Fold
increase
1
15
4.1
64

Mutation rates are medians for at least 18 cultures from two to three
independent clones. 95% confidence intervals are shown in parentheses.
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Figure 5.1. pol2-P301R mutants require functional Polδ proofreading for viability.
A. Tetrad analysis of yeast strains heterozygous for the pol3-D520V allele encoding exonucleasedeficient Polδ, pol2-P301R, or both pol3-D520V and pol2-P301R. No viable pol3-D520V pol2P301R spores were obtained from the pol3-D520V/POL3 POL2/pol2-P301R diploid.
B. Microcolonies formed by haploid pol3-D520V pol2-P301R spores. Photographs were taken at
200x magnification three days after placement of spores.
C. Diploids homozygous for both pol3-D520V and pol2-P301R are inviable. Cultures of diploid
strains carrying the indicated chromosomal alleles and pBL304 were serially diluted and plated
onto synthetic complete medium (SC, left) or medium containing 5-FOA to select for cells that
have lost pBL304 (right). The inability of pol3-D520V/pol3-D520V pol2-P301R/pol2-P301R
diploids to grow without pBL304 indicates synthetic lethality.
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produces a rather strong mutator phenotype (118). Thus, we used these strains to
assess the effect of the combination of pol3-D520V and pol2-P301R on mutagenesis.
We measured the mutation rate at two reporter loci, CAN1 and his7-2. All diploid strains
used in this chapter contain the CAN1::Kl.LEU2/can1Δ configuration described in
Chapter 2. We observed a strong synergistic increase in both CAN1 mutation and his7-2
reversion in the double mutant strains (Table 5.2), indicating that Polδ proofreading
removes a majority of Polε-P301R errors in vivo.

Correction of Polε-P301R errors by DNA mismatch repair
Haploid pol2-P301R msh6Δ strains are inviable, but the double mutant cells can
divide and form microcolonies before the growth stops (28). Like the inviability of pol2P301R pol3-D520V haploids, this phenotype is characteristic of death from excessive
levels of mutagenesis. It suggests that the number of mismatches generated by PolεP301R is overwhelming, even after extrinsic proofreading by Polδ, and Msh6-dependent
MMR is required to keep the mutation rate below the lethal threshold. We attempted to
construct diploid strains homozygous for both pol2-P301R and msh6Δ mutations, but
were unsuccessful, which suggested that the mutation rate was too high even for diploid
cells. Thus, MMR appears to be required for survival of strains containing Polε-P301R as
the sole source of Polε.This is in striking contrast to the pol2-4 strains containing Polεexo- that can tolerate a loss of MMR even in the haploid state (28,59,145) as pol2-4 is a
much weaker mutator.
Diploids heterozygous for the pol2-P301R mutation and homozygous for
msh6Δ, however, were viable. The combination of heterozygosity for pol2-P301R with
homozygosity for msh6Δ resulted in a synergistic increase in mutation rate for both the

73

Table 5.2. Synergistic interaction of pol2-P301R and Polδ proofreading deficiency
his7-2 reversion

CAN1 mutation
Genotype

POL2/POL2
POL3/POL3

Mutation rate
(x10-7)
3.4 (3.0-4.0)

Fold
increase
1

Mutation rate
(x10-8)
1.1 (0.85-1.3)

Fold
increase
1

POL2/POL2
pol3-D520V/pol3-D520V

46 (35-69)

14

17 (15-23)

15

POL2/pol2-P301R
POL3/POL3

75 (70-93)

22

29 (25-33)

26

POL2/pol2-P301R
pol3-D520V/pol3-D520V

3100 (2100-4500)

910

2800 (2200-3600)

2500

Mutation rates are medians for at least 18 cultures from two to three independent clones. 95%
confidence intervals are shown in parentheses.
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CAN1 and his7-2 reporters (Table 5.3). This demonstrates that MMR removes a majority
of Polε-P301R errors missed by proofreading and further supports the premise that
diploids homozygous for both pol2-P301R and msh6Δ die due to high levels of
mutagenesis. A synergistic increase in mutation rate was also observed when
heterozygosity for pol2-4 was combined with homozygosity for msh6Δ (Table 5.4), in
line with the synergy between pol2-4 and msh6Δ in haploids (28,59,145). However, the
absolute mutation rate in pol2-P301R/POL2 msh6Δ/msh6Δ diploids is an order of
magnitude higher than pol2-4/pol2-4 msh6Δ/msh6Δ diploids, once again illustrating the
unprecedented level of replication errors generated by Polε-P301R in vivo.

Discussion
The results presented in this chapter derive from experiments using the yeast
model to assess the impact of the P301R substitution in Polε on extrinsic error correction
systems. Due to a catastrophically high rate of leading strand errors, both MMR and
extrinsic proofreading by the exonuclease of Polδ are required for viability when PolεP301R is the sole Polε variant present in a cell. Synergistic increases in mutagenesis in
diploids heterozygous for the pol2-P301R allele and lacking either MMR or Polδ
exonuclease further demonstrate that Polε-P301R errors are efficiently corrected by Polδ
proofreading and MMR.
Studies of the Polε-P301R variant described here uncover the remarkable
efficiency at which extrinsic proofreading by Polδ operates to correct Polε errors. The
data presented in Chapter 3 demonstrated that the exonuclease of Polδ readily
proofreads errors made by Polε-exo- and another inaccurate Polε variant, Polε-M644G.
This extrinsic correction must involve dissociation of Polε from the primer terminus to

75

Table 5.3. Synergistic interaction of pol2-P301R and MMR deficiency
CAN1 mutation
Genotype

POL2/POL2
MSH6/MSH6

Mutation rate
(x10-7)
3.4 (3.0-4.0)

POL2/POL2
msh6Δ/msh6Δ

31 (28-36)

POL2/pol2-P301R
MSH6/MSH6

75 (70-93)

his7-2 reversion

Fold
increase

Mutation rate
(x10-8)

Fold
increase

1

1.1 (0.85-1.3)

1

9.1

4.6 (4.1-5.3)

4.2

22

29 (25-33)

26

POL2/pol2-P301R
4300 (3300-6000)
1300
105 (73-230)
95
msh6Δ/msh6Δ
Mutation rates are medians for at least 18 cultures from two to three independent clones.
95% confidence intervals are shown in parentheses.
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Table 5.4. Synergistic interaction of heterozygosity for pol2-4 with MMR deficiency
CAN1 mutation
Genotype

POL2/POL2
MSH6/MSH6
POL2/POL2
msh6Δ/msh6Δ
POL2/pol2-4
MSH6/MSH6
POL2/pol2-4
msh6Δ/msh6Δ

Mutation rate
(x10-7)
3.4 (3.0-4.0)
31 (28-36)
5.5 (4.6-6.6)
450 (390-530)

Fold
increase

his7-2 reversion
Mutation rate
(x10-8)

Fold
increase

1

1.1 (0.85-1.3)

1

9.1

4.6 (4.1-5.3)

4.2

1.6

4.5 (3.9-6.1)

4.1

130

36 (29-42)

33

Mutation rates are medians for at least 18 cultures from two to three
independent clones. 95% confidence intervals are shown in parentheses.
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allow Polδ access to the mismatch. The dissociation is presumably facilitated by a pause
in DNA synthesis, as replicative DNA polymerases are rather inefficient at extending
mismatched primer termini. Polε-P301R, however, is a hyperactive polymerase far
superior to other Polε variants in the ability to utilize a variety of DNA substrates,
including those with incorrectly paired primer ends (28). Structural studies showed that
the arginine side chain protrudes into the space normally occupied by the 3’-terminal
nucleotide in the exonuclease active site (124). The inability of Polε-P301R to
accommodate the primer terminus in the exonuclease site was proposed to not only
dramatically reduce exonuclease activity, but also to prompt Polε-P301R to stay in the
polymerization mode, resulting in increased polymerase activity, mismatch extension,
and ultimately an unprecedented mutator effect (28). The discovery that a majority of
errors generated by Polε-P301R are proofread by the exonuclease of Polδ was,
therefore, surprising. The strong synergistic interaction of pol2-P301R and pol3-D520V
mutations (Table 5.2) suggests that, despite superior mismatch extension capability,
Polε-P301R dissociates from the primer terminus upon misinserting a nucleotide in
>97% of cases and allows Polδ to correct the error. This finding illustrates the
robustness of the extrinsic proofreading mechanism and suggests that the switch from
Polε to Polδ on the leading strand is easier than one could expect, as it is much
preferred to even a very efficient mismatch extension by Polε. Completion of leading
strand synthesis after removal of the mismatch could conceivably occur by Polδ or,
alternatively, involve switching back to Polε-P301R. Recent findings that DNA replication
begins with Polδ extending Polα-synthesized primers on both the leading and lagging
strands suggests that there is, indeed, a mechanism for Polδ to hand off the leading
strand to Polε as synthesis catches up with the moving helicase (76-78). On the other
hand, intramolecular switching from the exonuclease to the polymerase active site has
been suggested for Polδ (57). Intramolecular switching between active sites has also
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been demonstrated for bacteriophage RB69 and T4 DNA polymerases, as well as for the
eukaryotic Polε (56,163,164). The results presented in Chapter 4 indicate that in the vast
majority of cases, the leading strand is synthesized by Polε until the termination zone,
but a small proportion synthesized by Polδ, such as that expected from extrinsic
proofreading and subsequent Polδ-driven extension, would not be detected.
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Chapter 6: Discussion, conclusions, and future
directions
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Discussion
Genome stability requires redundancy of replication fidelity mechanisms.
The overlap in replication and repair mechanisms is essential to prevent lethal
and pathogenic mutations and ensure the stability of DNA. For example, several DNA
glycosylases function in base excision repair such that when one is compromised the
others can compensate (165). Multiple translesion synthesis polymerases provide
redundant mechanisms of lesion bypass (166,167). Cancer cells in which one DNA
repair pathway has been compromised become resistant to DNA-damaging therapeutic
drugs in part due to the redundancy that exists to repair the damage and prevent
mutations. Targeting a redundant repair pathway in combination with a DNA damaging
agent is a promising approach to overcome resistance (168). A recent example is the
inclusion of nucleoside analog 5-NIdR, an inhibitor of translesion synthesis, with
temozolomide in treatment of homologous-recombination-impaired tumors to promote
cancer cell death (169,170).
The redundancy that serves to protect the genome is also found in the DNA
replication process. It is well established that three different mechanisms, nucleotide
selectivity, exonucleolytic proofreading, and MMR, act to prevent and correct replication
errors. A combination of nucleotide selectivity and proofreading defects in Polδ results in
a catastrophically high mutation rate incompatible with life in haploid yeast (162),
indicating that proofreading normally compensates for reduced nucleotide selectivity.
Haploid yeast deficient in Polδ proofreading require functional MMR for survival (142).
Recent work has demonstrated that polymerase fidelity and MMR can compensate for
defects in cellular metabolism that lead to dNTP pool imbalances and help maintain a
normal low mutation rate despite the abnormal dNTP levels (171,172). Extrinsic
proofreading of Polε errors by Polδ shown in Chapter 3, as well as proofreading of Polα
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errors by Polδ shown previously (74) is yet another mechanism of redundancy to prevent
accumulation of DNA replication errors.

Implications for the etiology of POLE-mutant tumors
The studies presented in this dissertation have implications for human cancer
biology. Mutations in the POLE gene, which encodes the catalytic subunit of Polε in
humans, are found in sporadic colorectal and endometrial tumors (61). POLE-mutant
tumors have the highest mutation load across different cancer types [>100 mutations per
Mb; (90,91,105)]. The POLE mutations predominantly affect the exonuclease domain of
Polε and cause strong mutator and cancer susceptibility phenotype in model systems
(118,120,173). Although MMR defects are also common in colorectal and endometrial
tumors, strong POLE mutators are never seen in combination with MMR deficiency,
suggesting that MMR is critical to keep the mutation rate at a level compatible with cell
survival. Thus, POLE and MMR defects appear to be mutually exclusive. While a small
number of tumors with a combination of a POLE mutation and a MMR defect have been
reported (61), these POLE alleles confer only a weak mutator effect in functional assays
(173). Brain tumors in children with biallelic MMR deficiency often contain POLE
mutations (101,174), but, again, these tumors usually harbor only partial MMR defects
and weaker POLE mutators. No tumors with microsatellite instability and the POLEP286R mutation have been found to date. There could be two possible explanations for
the apparent incompatibility of strong POLE mutators with MMR deficiency. First, since
either defect is sufficient to cause a tumor, the combination of a strong POLE mutator
with a loss of MMR would only be detected if it occurred by chance, and the probability
of acquiring both defects simultaneously is relatively low. This explanation seems
unlikely given the large number of POLE-P286R reported (>200) and no documented
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cases of MMR deficiency among those. One pancreatic tumor in TCGA database carried
POLE-P286R along with two nonsense mutations in MSH6 (81). However, there is no
evidence that the MSH6 mutations impacted different alleles or that the tumor had
microsatellite instability. For comparison, approximately 10% of colorectal and 28% of
endometrial cancers without POLE mutations are MMR deficient (90,91). The second
explanation suggested by our finding in yeast (Chapter 5) is that the combination of
strong POLE mutators with MMR deficiency is incompatible with cell viability because
the mutation rate in such cells exceeds the maximum tolerated threshold. Although
diploid cells can withstand relatively high levels of mutagenesis, they do have a viability
threshold (162), and, indeed, we observed that yeast diploids homozygous for both pol2P301R and msh6 mutations do not survive. It is noteworthy that the POLE mutations are
usually present in heterozygous state in tumors (61,95) but are still not seen together
with MMR defects, a combination that is viable in yeast (Chapter 5). It is possible that
human cells, due to their more complex biology, have a lower viability threshold. It is
also possible that while formally compatible with cell viability, the high mutation rate
resulting from a combination of heterozygous POLE variants with a MMR defect is not
compatible with the level of fitness required for the sustained proliferation of cancer cells
within the human organism. Finally, it is possible that a full MMR defect such as that
resulting from an mlh1 or msh2 mutation would be incompatible with the heterozygosity
for pol2-P301R in yeast either, as the msh6 mutation we employed leaves the Msh3dependent MMR functional. These possibilities could be further investigated in the
future. Our results strongly suggest that the corresponding defects in human cells are
mutually exclusive because of a catastrophically high mutation rate.
Curiously, mutations affecting the exonuclease domain of Polδ are seen much
less frequently than mutations affecting the exonuclease domain of Polε in sporadic
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tumors. While never explicitly tested, it is possible that these result in much stronger
mutator phenotypes that hamper cell proliferation, and POLE-mutant cancers survive
because extrinsic proofreading by Polδ helps reduce the number of errors to a tolerable
level. Studies in mouse models suggested that the relative contributions of Polδ and Polε
proofreading activities to replication fidelity and cancer prevention could vary depending
on the cell and tissue type, as well as developmental stage. In a MMR-deficient
background, both Polδ and Polε proofreading defects are lethal, but embryos lacking
Polδ proofreading die earlier than those lacking Polε proofreading (119). In MMRproficient background, a Polδ proofreading defect leads to a significantly earlier onset of
cancer than the analogous defect in Polε (119,175,176). These observations are
reminiscent of the stronger effects of Polδ mutations in yeast, although dramatic
differences in the spectrum of tumors in Polδ versus Polε mutant mice preclude accurate
comparison of cancer susceptibility. A combination of Polδ and Polε proofreading
defects, however, greatly accelerates the development of tumors characteristic of Polδ
proofreading deficiency (119), consistent with the idea that tumors in Polδ proofreadingdeficient mice result, in part, from Polε errors. Curiously, neither the stronger effects of
Polδ exonuclease nor synergy between Polδ and Polε was detected when the mutation
rate was measured in fibroblast cell lines derived from the mutant embryos (119). These
studies illuminate the complexity of the mammalian developmental and tissue biology,
and highlight the importance of investigating possible cooperation of Polδ and Polε
exonucleases in cancer-relevant cells and tissues.
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Conclusions
The results presented in Chapter 3 of this dissertation established a one-sided
extrinsic proofreading mechanism for maintaining DNA replication fidelity. The synergy in
mutation rate between a Polε nucleotide selectivity defect and a Polδ proofreading
defect indicate that Polδ proofreading acts in series with Polε nucleotide selectivity,
establishing that Polδ can and does proofread errors generated by Polε. Furthermore,
the additivity in mutation rate observed between a Polδ nucleotide selectivity defect and
a Polε proofreading defect indicate that Polδ nucleotide selectivity and Polε proofreading
act in independent pathways, establishing that Polε cannot proofread errors generated
by Polδ.
In Chapter 4, the genetic system we developed allows for discrimination between
leading and lagging strand errors because both Polε-exo- and Polε-P301R are biased in
the formation of reciprocal mispairs. Both polymerase variants are more prone to
misinsertion across from template C than from template G, so when the reporter allele
has C in the template strand, then the majority of errors made by either Polε-exo- or
Polε-P301R occur during replication of that strand. Our results show that both Polε-exoand Polε-P301R synthesize the leading DNA strand from the origin of DNA replication to
the termination zone.
The experiments in Chapter 5 analyzed removal of Polε-P301R-generated errors
by extrinsic proofreading and MMR. Combining either a Polδ proofreading defect or a
MMR defect with pol2-P301R in haploid yeast is lethal. Furthermore, diploid yeast
homozygous for pol2-P301R/pol2-P301R and lacking either MMR or Polδ proofreading
also did not survive. When we combined a Polδ proofreading defect with heterozygosity
for pol2-P301R, we observed a large synergistic increase in mutation rate for two
reporters, which demonstrated that Polδ proofreads major portion of Polε-P301R-
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generated errors. Similarly, there was a synergistic increase in the mutation rate when a
MMR defect was added to strains heterozygous for pol2-P301R, indicating that MMR
corrects the majority of Polε-P301R-generated errors that remain after extrinsic
proofreading by Polδ.
Together, the results presented in this dissertation establish that Polε copies the
leading strand from origin to the termination zone during DNA replication, and any errors
missed by intrinsic proofreading are subject to correction by the exonuclease of Polδ.
Importantly, the experiments presented here demonstrate that two fundamental
properties of Polε (strand specificity and correction of its errors by Polδ and MMR) are
not lost with the P301R substitution, even though Polε-P301R is a hyperactive enzyme
with unrivaled mismatch extension and generates errors at a rate an order of magnitude
higher than proofreading-deficient Polε.

Future directions
Does Polε participate in leading strand replication in late replicating
regions?
The replicon used in Chapter 4 to measure mutation accumulation between the
origin and termination zones occurs between two very efficient and early firing replication
origins. Earlier genome-wide studies of ribonucleotide incorporation averaged data from
all replicons and did not see a strong bias for leading strand replication by Polε near
termination zones. If there is a difference in the organization of the replication fork near
termination zones in early and late replicating regions, this could reduce the apparent
bias of Polε for the leading strand near termination zones when averaging all replicons.
To answer whether Polε participation in leading strand synthesis is maintained during
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late replication, the mutation accumulation studies could be repeated in a late-replicating
region of the genome. ARS727 and ARS728 are two efficient replication origins that fire
later in S-phase (12), and thus the termination zone is defined. The ura3-29 reporter
could be inserted at several locations between coordinates 659806 and 715187 on
chromosome VII, and mutation rates measured in pol2-4 strains to determine the
participation and strand bias of Polε in this late-replicating region.

How does extrinsic proofreading of Polε errors by Polδ vary across the
replicon?
The results in Chapter 3 demonstrated that Polδ proofreads Polε-generated
errors, and results in Chapter 4 showed a strict leading strand bias of Polε-generated
errors. Given that MMR balances differences in fidelity on leading and lagging strands,
as well as in early versus late replicating regions, the extent of extrinsic proofreading of
Polε errors by Polδ may also vary across the replicon. To probe the extent of extrinsic
proofreading across the replicon, the mutation accumulation experiments described in
Chapter 4 could be adapted to measure the extent of synergy between pol2-4 and pol3D520V mutations. Measuring ura3-29 reversion at each of the six locations in strains
with pol2-4 mutation, pol3-D520V mutation, or both mutations would give a picture of the
extent of extrinsic proofreading at various locations between the origin of replication and
termination zone.

Why are so many pol2-P301R-generated mutations observed in vivo?
Previous studies established that Polε-P301R is not more mutagenic than Polεexo- in vitro, yet the in vivo mutation rate is an order of magnitude higher (28,118). The
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increased polymerase activity and mismatch extension capabilities of Polε-P301R lead
to the hypothesis that Polε-P301R extends and incorporate mismatches into the genome
better than Polε-exo- (28). The results presented in this dissertation show that PolεP301R errors are corrected by both Polδ proofreading and MMR, yet the mutation rate in
pol2-P301R strains lacking MMR or Polδ proofreading is still much higher than isogenic
pol2-4 strains. So, what is the mechanism by which more errors generated by PolεP301R are incorporated into the genome? One hypothesis is that there is an unknown
factor capable of extrinsically proofreading Polε-exo- errors that is blocked by PolεP301R. To test this possibility, one could screen for genes that, when deleted or
mutated, are synergistic with pol2-4 but not pol2-P301R. Alternatively, one could identify
mutations that suppress the mutator phenotype in pol2-P301R strains. Uncovering the
differences between pol2-4 and pol2-P301R strains would help illuminate the molecular
mechanism by which Polε-P301R errors become inserted in the genome at such high
rates.

Does MMR saturation occur in diploid strains harboring error-prone Polε
variants and lacking Polδ proofreading?
The mutation rate in pol2-4/POL2 pol3-D520V/pol3-D520V is approximately two
times greater than expected from a multiplicative interaction between pol2-4 and pol3D520V (Table 5.1). Likewise, the mutation rate in pol2-P301R/POL2 pol3-D520V/pol3D520V strains is approximately three times greater than expected from a multiplicative
interaction between pol2-P301R and pol3-D520V (Table 5.2). This could be expected if
there is a partial MMR defect in these strains due to saturation of MMR. To test whether
there is an MMR defect, a triple mutant strain harboring a Polε variant (either exo- or
P301R) and lacking Polδ proofreading and MMR would be necessary. Since the
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expected multiplicative mutation rate in a pol2-P301R/POL2 pol3-D520V/pol3-D520V
msh6Δ/msh6Δ strain would exceed the viability threshold for diploids, higher ploidy
would be required. However, a pol2-4/POL2 pol3-D520V/pol3-D520V msh6Δ/msh6Δ
could potentially survive, though careful construction would be necessary to avoid
potential accumulation of suppressor mutations. Measuring mutation rate in single,
double, and triple mutant cells would reveal whether the relationship is fully multiplicative
or not, and thus whether there is a MMR defect in strains lacking Polδ proofreading and
harboring a Polε variant. If we observe a multiplicative increase in mutation rate when
we delete MSH6 in pol2-4/POL2 pol3-D520V/pol3-D520V strains, then it will be clear
that there is no MMR defect in the pol2-4/POL2 pol3-D520V/pol3-D520V strains.

To what extent do intrinsic proofreading, extrinsic proofreading, and MMR
contribute to the fidelity of the leading strand replication?
If an incorrect nucleotide is incorporated by Polε during replication of the leading
strand, there are at least three ways the error can be removed: intrinsic proofreading by
Polε, extrinsic proofreading by Polδ, and post-replicative MMR. It is not known how
much each error correction system does to maintain the low rate of mutations during
DNA replication. To address the extent of intrinsic proofreading, the pol2-M644G
mutation could be combined with the pol2-4 mutation in the absence of Polδ
proofreading, MMR, or both. Measuring mutation rates in these yeast strains would
establish the extent of removal for each error correction system. Since previous studies
and experiments presented in this dissertation have established that all three
mechanisms act in series with nucleotide selectivity of Polε, diploid strains, or potentially
strains with higher ploidy, would likely be necessary.
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How much does extrinsic proofreading by Polδ contribute to replication
fidelity on the lagging strand?
It has been established that Polδ proofreads errors made by Polα and Polε
[(74,161) and Chapter 3]. Additionally, both pol3-D520V and pol3-01 alleles appear to be
nearly recessive (53,142,146), suggesting that Polδ molecules can proofread for other
Polδ molecules on the lagging strand. The extent to which Polδ intrinsically and
extrinsically proofreads lagging strand errors has not been studied. To investigate
intrinsic proofreading by Polδ, combining the pol3-L612M and pol3-D520V mutations into
a single allele (in diploid strains as haploids are likely to be inviable), could establish the
extent of intrinsic proofreading. Combining this double mutant allele with a pol3-D520V
mutation in the other allele of a diploid, and measuring mutation rates, could establish
the extent of extrinsic proofreading of Polδ errors. It may also be important to conduct
these mutation rate measurements in the absence of MMR, though the mutation rates
may exceed the viability threshold, preventing inactivation of MMR.

90

References
1.

Bell, S.P. and Stillman, B. (1992) ATP-dependent recognition of eukaryotic
origins of DNA replication by a multiprotein complex. Nature, 357, 128-134.

2.

Symeonidou, I.E., Taraviras, S. and Lygerou, Z. (2012) Control over DNA
replication in time and space. FEBS Lett., 586, 2803-2812.

3.

Evrin, C., Clarke, P., Zech, J., Lurz, R., Sun, J., Uhle, S., Li, H., Stillman, B. and
Speck, C. (2009) A double-hexameric MCM2-7 complex is loaded onto origin
DNA during licensing of eukaryotic DNA replication. Proc. Natl. Acad. Sci. U.S.A.,
106, 20240-20245.

4.

Remus, D., Beuron, F., Tolun, G., Griffith, J.D., Morris, E.P. and Diffley, J.F.
(2009) Concerted loading of Mcm2-7 double hexamers around DNA during DNA
replication origin licensing. Cell, 139, 719-730.

5.

Hanlon, S.L. and Li, J.J. (2015) Re-replication of a centromere induces
chromosomal instability and aneuploidy. PLoS Genet., 11, e1005039.

6.

Yeeles, J.T., Deegan, T.D., Janska, A., Early, A. and Diffley, J.F. (2015)
Regulated eukaryotic DNA replication origin firing with purified proteins. Nature,
519, 431-435.

7.

Langston, L.D., Zhang, D., Yurieva, O., Georgescu, R.E., Finkelstein, J., Yao,
N.Y., Indiani, C. and O'Donnell, M.E. (2014) CMG helicase and DNA polymerase
ε form a functional 15-subunit holoenzyme for eukaryotic leading-strand DNA
replication. Proc. Natl. Acad. Sci. U.S.A., 111, 15390-15395.

8.

Boos, D. and Ferreira, P. (2019) Origin Firing Regulations to Control Genome
Replication Timing. Genes (Basel), 10.

9.

Doublie, S. and Zahn, K.E. (2014) Structural insights into eukaryotic DNA
replication. Front. Microbiol., 5, 444.

10.

Marks, A.B., Fu, H. and Aladjem, M.I. (2017) Regulation of Replication Origins.
Adv. Exp. Med. Biol., 1042, 43-59.

11.

Parker, M.W., Botchan, M.R. and Berger, J.M. (2017) Mechanisms and
regulation of DNA replication initiation in eukaryotes. Crit. Rev. Biochem. Mol.
Biol., 52, 107-144.

12.

McGuffee, S.R., Smith, D.J. and Whitehouse, I. (2013) Quantitative, genomewide analysis of eukaryotic replication initiation and termination. Mol. Cell, 50,
123-135.

13.

Garg, P. and Burgers, P.M. (2005) DNA polymerases that propagate the
eukaryotic DNA replication fork. Crit. Rev. Biochem. Mol. Biol., 40, 115-128.

91
14.

Morrison, A., Araki, H., Clark, A.B., Hamatake, R.K. and Sugino, A. (1990) A third
essential DNA polymerase in S. cerevisiae. Cell, 62, 1143-1151.

15.

Baranovskiy, A.G., Siebler, H.M., Pavlov, Y.I. and Tahirov, T.H. (2018) IronSulfur Clusters in DNA Polymerases and Primases of Eukaryotes. Methods
Enzymol., 599, 1-20.

16.

Muzi-Falconi, M., Giannattasio, M., Foiani, M. and Plevani, P. (2003) The DNA
polymerase alpha-primase complex: multiple functions and interactions.
ScientificWorldJournal, 3, 21-33.

17.

Reijns, M.A.M., Kemp, H., Ding, J., de Proce, S.M., Jackson, A.P. and Taylor,
M.S. (2015) Lagging-strand replication shapes the mutational landscape of the
genome. Nature, 518, 502-506.

18.

Sun, J., Yuan, Z., Georgescu, R., Li, H. and O'Donnell, M. (2016) The eukaryotic
CMG helicase pumpjack and integration into the replisome. Nucleus, 7, 146-154.

19.

Yuan, Z., Georgescu, R., Schauer, G.D., O'Donnell, M.E. and Li, H. (2020)
Structure of the polymerase epsilon holoenzyme and atomic model of the leading
strand replisome. Nat Commun, 11, 3156.

20.

Tahirov, T.H., Makarova, K.S., Rogozin, I.B., Pavlov, Y.I. and Koonin, E.V.
(2009) Evolution of DNA polymerases: an inactivated polymerase-exonuclease
module in Pol ε and a chimeric origin of eukaryotic polymerases from two classes
of archaeal ancestors. Biol. Direct, 4, 11.

21.

Kesti, T., Flick, K., Keranen, S., Syvaoja, J.E. and Wittenberg, C. (1999) DNA
polymerase ε catalytic domains are dispensable for DNA replication, DNA repair,
and cell viability. Mol. Cell, 3, 679-685.

22.

Boulet, A., Simon, M., Faye, G., Bauer, G.A. and Burgers, P.M. (1989) Structure
and function of the Saccharomyces cerevisiae CDC2 gene encoding the large
subunit of DNA polymerase III. EMBO J., 8, 1849-1854.

23.

Garcia-Diaz, M. and Bebenek, K. (2007) Multiple functions of DNA polymerases.
CRC Crit Rev Plant Sci, 26, 105-122.

24.

Bebenek, A. and Ziuzia-Graczyk, I. (2018) Fidelity of DNA replication-a matter of
proofreading. Curr. Genet., 64, 985-996.

25.

Kunkel, T.A. and Erie, D.A. (2015) Eukaryotic mismatch repair in relation to DNA
replication. Annu. Rev. Genet., 49, 291-313.

26.

Lynch, M. (2010) Evolution of the mutation rate. Trends Genet., 26, 345-352.

27.

Fortune, J.M., Pavlov, Y.I., Welch, C.M., Johansson, E., Burgers, P.M. and
Kunkel, T.A. (2005) Saccharomyces cerevisiae DNA polymerase delta: high
fidelity for base substitutions but lower fidelity for single- and multi-base
deletions. J. Biol. Chem., 280, 29980-29987.

92
28.

Xing, X., Kane, D.P., Bulock, C.R., Moore, E.A., Sharma, S., Chabes, A. and
Shcherbakova, P.V. (2019) A recurrent cancer-associated substitution in DNA
polymerase ε produces a hyperactive enzyme. Nat. Commun., 10, 374.

29.

St Charles, J.A., Liberti, S.E., Williams, J.S., Lujan, S.A. and Kunkel, T.A. (2015)
Quantifying the contributions of base selectivity, proofreading and mismatch
repair to nuclear DNA replication in Saccharomyces cerevisiae. DNA Repair, 31,
41-51.

30.

Watson, J.D. and Crick, F.H. (1953) Genetical implications of the structure of
deoxyribonucleic acid. Nature, 171, 964-967.

31.

Watson, J.D. and Crick, F.H. (1953) Molecular structure of nucleic acids; a
structure for deoxyribose nucleic acid. Nature, 171, 737-738.

32.

Echols, H. and Goodman, M.F. (1991) Fidelity mechanisms in DNA replication.
Annu. Rev. Biochem., 60, 477-511.

33.

Goodman, M.F. (1997) Hydrogen bonding revisited: geometric selection as a
principal determinant of DNA replication fidelity. Proc. Natl. Acad. Sci. U.S.A., 94,
10493-10495.

34.

Kunkel, T.A. (2004) DNA replication fidelity. J. Biol. Chem., 279, 16895-16898.

35.

Moran, S., Ren, R.X. and Kool, E.T. (1997) A thymidine triphosphate shape
analog lacking Watson-Crick pairing ability is replicated with high sequence
selectivity. Proc. Natl. Acad. Sci. U.S.A., 94, 10506-10511.

36.

Moran, S., Ren, R.X., Rumney, S. and Kool, E.T. (1997) Difluorotoluene, a
Nonpolar Isostere for Thymine, Codes Specifically and Efficiently for Adenine in
DNA Replication. J. Am. Chem. Soc., 119, 2056-2057.

37.

Lessor, R.A., Gibson, K.J. and Leonard, N.J. (1984) Synthesis and biochemical
evaluation of 2'-deoxy-lin-benzoadenosine phosphates. Biochemistry, 23, 38683873.

38.

Morales, J.C. and Kool, E.T. (1998) Efficient replication between non-hydrogenbonded nucleoside shape analogs. Nat. Struct. Biol., 5, 950-954.

39.

Matray, T.J. and Kool, E.T. (1999) A specific partner for abasic damage in DNA.
Nature, 399, 704-708.

40.

Kool, E.T., Morales, J.C. and Guckian, K.M. (2000) Mimicking the Structure and
Function of DNA: Insights into DNA Stability and Replication. Angew. Chem. Int.
Ed. Engl., 39, 990-1009.

41.

O'Neill, B.M., Ratto, J.E., Good, K.L., Tahmassebi, D.C., Helquist, S.A., Morales,
J.C. and Kool, E.T. (2002) A highly effective nonpolar isostere of
deoxyguanosine: synthesis, structure, stacking, and base pairing. J. Org. Chem.,
67, 5869-5875.

93
42.

Joyce, C.M. (1997) Choosing the right sugar: how polymerases select a
nucleotide substrate. Proc. Natl. Acad. Sci. U.S.A., 94, 1619-1622.

43.

Herr, A.J., Williams, L.N. and Preston, B.D. (2011) Antimutator variants of DNA
polymerases. Crit. Rev. Biochem. Mol. Biol., 46, 548-570.

44.

Niimi, A., Limsirichaikul, S., Yoshida, S., Iwai, S., Masutani, C., Hanaoka, F.,
Kool, E.T., Nishiyama, Y. and Suzuki, M. (2004) Palm mutants in DNA
polymerases α and η alter DNA replication fidelity and translesion activity. Mol.
Cell. Biol., 24, 2734-2746.

45.

Nick McElhinny, S.A., Stith, C.M., Burgers, P.M. and Kunkel, T.A. (2007)
Inefficient proofreading and biased error rates during inaccurate DNA synthesis
by a mutant derivative of Saccharomyces cerevisiae DNA polymerase δ. J. Biol.
Chem., 282, 2324-2332.

46.

Pursell, Z.F., Isoz, I., Lundstrom, E.B., Johansson, E. and Kunkel, T.A. (2007)
Yeast DNA polymerase ε participates in leading-strand DNA replication. Science,
317, 127-130.

47.

Nick McElhinny, S.A., Watts, B.E., Kumar, D., Watt, D.L., Lundstrom, E.B.,
Burgers, P.M., Johansson, E., Chabes, A. and Kunkel, T.A. (2010) Abundant
ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc.
Natl. Acad. Sci. U.S.A., 107, 4949-4954.

48.

Kunkel, T.A., Hamatake, R.K., Motto-Fox, J., Fitzgerald, M.P. and Sugino, A.
(1989) Fidelity of DNA polymerase I and the DNA polymerase I-DNA primase
complex from Saccharomyces cerevisiae. Mol. Cell. Biol., 9, 4447-4458.

49.

Shcherbakova, P.V., Pavlov, Y.I., Chilkova, O., Rogozin, I.B., Johansson, E. and
Kunkel, T.A. (2003) Unique error signature of the four-subunit yeast DNA
polymerase ε. J. Biol. Chem., 278, 43770-43780.

50.

Fortune, J.M., Stith, C.M., Kissling, G.E., Burgers, P.M. and Kunkel, T.A. (2006)
RPA and PCNA suppress formation of large deletion errors by yeast DNA
polymerase delta. Nucleic Acids Res., 34, 4335-4341.

51.

Blanco, L., Bernad, A. and Salas, M. (1992) Evidence favouring the hypothesis of
a conserved 3'-5' exonuclease active site in DNA-dependent DNA polymerases.
Gene, 112, 139-144.

52.

Morrison, A., Bell, J.B., Kunkel, T.A. and Sugino, A. (1991) Eukaryotic DNA
polymerase amino acid sequence required for 3'----5' exonuclease activity. Proc.
Natl. Acad. Sci. U.S.A., 88, 9473-9477.

53.

Simon, M., Giot, L. and Faye, G. (1991) The 3' to 5' exonuclease activity located
in the DNA polymerase δ subunit of Saccharomyces cerevisiae is required for
accurate replication. EMBO J., 10, 2165-2170.

54.

Jin, Y.H., Obert, R., Burgers, P.M., Kunkel, T.A., Resnick, M.A. and Gordenin,
D.A. (2001) The 3'-->5' exonuclease of DNA polymerase δ can substitute for the

94
5' flap endonuclease Rad27/Fen1 in processing Okazaki fragments and
preventing genome instability. Proc. Natl. Acad. Sci. U.S.A., 98, 5122-5127.
55.

Reha-Krantz, L.J. (1998) Regulation of DNA polymerase exonucleolytic
proofreading activity: studies of bacteriophage T4 "antimutator" DNA
polymerases. Genetics, 148, 1551-1557.

56.

Ganai, R.A., Bylund, G.O. and Johansson, E. (2015) Switching between
polymerase and exonuclease sites in DNA polymerase ε. Nucleic Acids Res., 43,
932-942.

57.

Jin, Y.H., Garg, P., Stith, C.M., Al-Refai, H., Sterling, J.F., Murray, L.J., Kunkel,
T.A., Resnick, M.A., Burgers, P.M. and Gordenin, D.A. (2005) The multiple
biological roles of the 3'-->5' exonuclease of Saccharomyces cerevisiae DNA
polymerase δ require switching between the polymerase and exonuclease
domains. Mol. Cell. Biol., 25, 461-471.

58.

Shcherbakova, P.V. and Pavlov, Y.I. (1996) 3'-->5' exonucleases of DNA
polymerases ε and δ correct base analog induced DNA replication errors on
opposite DNA strands in Saccharomyces cerevisiae. Genetics, 142, 717-726.

59.

Tran, H.T., Gordenin, D.A. and Resnick, M.A. (1999) The 3'-->5' exonucleases of
DNA polymerases δ and ε and the 5'-->3' exonuclease Exo1 have major roles in
postreplication mutation avoidance in Saccharomyces cerevisiae. Mol. Cell. Biol.,
19, 2000-2007.

60.

Loeb, L.A., Springgate, C.F. and Battula, N. (1974) Errors in DNA replication as a
basis of malignant changes. Cancer Res., 34, 2311-2321.

61.

Barbari, S.R. and Shcherbakova, P.V. (2017) Replicative DNA polymerase
defects in human cancers: Consequences, mechanisms, and implications for
therapy. DNA Repair (Amst), 56, 16-25.

62.

Modrich, P. and Lahue, R. (1996) Mismatch repair in replication fidelity, genetic
recombination, and cancer biology. Annu. Rev. Biochem., 65, 101-133.

63.

Hombauer, H., Srivatsan, A., Putnam, C.D. and Kolodner, R.D. (2011) Mismatch
repair, but not heteroduplex rejection, is temporally coupled to DNA replication.
Science, 334, 1713-1716.

64.

Thomas, D.C., Umar, A. and Kunkel, T.A. (1996) Microsatellite instability and
mismatch repair defects in cancer. Mutat. Res., 350, 201-205.

65.

Hawk, J.D., Stefanovic, L., Boyer, J.C., Petes, T.D. and Farber, R.A. (2005)
Variation in efficiency of DNA mismatch repair at different sites in the yeast
genome. Proc. Natl. Acad. Sci. U.S.A., 102, 8639-8643.

66.

Pavlov, Y.I., Mian, I.M. and Kunkel, T.A. (2003) Evidence for preferential
mismatch repair of lagging strand DNA replication errors in yeast. Curr. Biol., 13,
744-748.

95
67.

Lujan, S.A., Williams, J.S., Pursell, Z.F., Abdulovic-Cui, A.A., Clark, A.B., Nick
McElhinny, S.A. and Kunkel, T.A. (2012) Mismatch repair balances leading and
lagging strand DNA replication fidelity. PLoS Genet., 8, e1003016.

68.

Lujan, S.A., Clausen, A.R., Clark, A.B., MacAlpine, H.K., MacAlpine, D.M., Malc,
E.P., Mieczkowski, P.A., Burkholder, A.B., Fargo, D.C., Gordenin, D.A. et al.
(2014) Heterogeneous polymerase fidelity and mismatch repair bias genome
variation and composition. Genome Res., 24, 1751-1764.

69.

Nick McElhinny, S.A., Gordenin, D.A., Stith, C.M., Burgers, P.M. and Kunkel,
T.A. (2008) Division of labor at the eukaryotic replication fork. Mol. Cell, 30, 137144.

70.

Larrea, A.A., Lujan, S.A., Nick McElhinny, S.A., Mieczkowski, P.A., Resnick,
M.A., Gordenin, D.A. and Kunkel, T.A. (2010) Genome-wide model for the
normal eukaryotic DNA replication fork. Proc. Natl. Acad. Sci. U.S.A., 107,
17674-17679.

71.

Shinbrot, E., Henninger, E.E., Weinhold, N., Covington, K.R., Goksenin, A.Y.,
Schultz, N., Chao, H., Doddapaneni, H., Muzny, D.M., Gibbs, R.A. et al. (2014)
Exonuclease mutations in DNA polymerase epsilon reveal replication strand
specific mutation patterns and human origins of replication. Genome Res., 24,
1740-1750.

72.

Clausen, A.R., Lujan, S.A., Burkholder, A.B., Orebaugh, C.D., Williams, J.S.,
Clausen, M.F., Malc, E.P., Mieczkowski, P.A., Fargo, D.C., Smith, D.J. et al.
(2015) Tracking replication enzymology in vivo by genome-wide mapping of
ribonucleotide incorporation. Nat. Struct. Mol. Biol., 22, 185-191.

73.

Daigaku, Y., Keszthelyi, A., Muller, C.A., Miyabe, I., Brooks, T., Retkute, R.,
Hubank, M., Nieduszynski, C.A. and Carr, A.M. (2015) A global profile of
replicative polymerase usage. Nat. Struct. Mol. Biol., 22, 192-198.

74.

Pavlov, Y.I., Frahm, C., Nick McElhinny, S.A., Niimi, A., Suzuki, M. and Kunkel,
T.A. (2006) Evidence that errors made by DNA polymerase α are corrected by
DNA polymerase δ Curr. Biol., 16, 202-207.

75.

Garg, P., Stith, C.M., Sabouri, N., Johansson, E. and Burgers, P.M. (2004) Idling
by DNA polymerase δ maintains a ligatable nick during lagging-strand DNA
replication. Genes Dev., 18, 2764-2773.

76.

Yeeles, J.T.P., Janska, A., Early, A. and Diffley, J.F.X. (2017) How the eukaryotic
replisome achieves rapid and efficient DNA replication. Mol. Cell, 65, 105-116.

77.

Aria, V. and Yeeles, J.T.P. (2018) Mechanism of bidirectional leading-strand
synthesis establishment at eukaryotic DNA replication origins. Mol. Cell, 73, 199211.

78.

Garbacz, M.A., Lujan, S.A., Burkholder, A.B., Cox, P.B., Wu, Q., Zhou, Z.X.,
Haber, J.E. and Kunkel, T.A. (2018) Evidence that DNA polymerase δ contributes

96
to initiating leading strand DNA replication in Saccharomyces cerevisiae. Nat.
Commun., 9, 858.
79.

Zhou, Z.X., Lujan, S.A., Burkholder, A.B., Garbacz, M.A. and Kunkel, T.A. (2019)
Roles for DNA polymerase δ in initiating and terminating leading strand DNA
replication. Nat. Commun., 10, 3992.

80.

Billingsley, C.C., Cohn, D.E., Mutch, D.G., Stephens, J.A., Suarez, A.A. and
Goodfellow, P.J. (2015) Polymerase ε (POLE) mutations in endometrial cancer:
clinical outcomes and implications for Lynch syndrome testing. Cancer, 121, 386394.

81.

Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A.,
Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer
genomics portal: an open platform for exploring multidimensional cancer
genomics data. Cancer Discov., 2, 401-404.

82.

Church, D.N., Briggs, S.E., Palles, C., Domingo, E., Kearsey, S.J., Grimes, J.M.,
Gorman, M., Martin, L., Howarth, K.M., Hodgson, S.V. et al. (2013) DNA
polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum.
Mol. Genet., 22, 2820-2828.

83.

Domingo, E., Freeman-Mills, L., Rayner, E., Glaire, M., Briggs, S., Vermeulen, L.,
Fessler, E., Medema, J.P., Boot, A., Morreau, H. et al. (2016) Somatic POLE
proofreading domain mutation, immune response, and prognosis in colorectal
cancer: a retrospective, pooled biomarker study. Lancet Gastroenterol. Hepatol.,
1, 207-216.

84.

Guerra, J., Pinto, C., Pinto, D., Pinheiro, M., Silva, R., Peixoto, A., Rocha, P.,
Veiga, I., Santos, C., Santos, R. et al. (2017) POLE somatic mutations in
advanced colorectal cancer. Cancer Med., 6, 2966-2971.

85.

Haruma, T., Nagasaka, T., Nakamura, K., Haraga, J., Nyuya, A., Nishida, T.,
Goel, A., Masuyama, H. and Hiramatsu, Y. (2018) Clinical impact of endometrial
cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite
instability. PLoS One, 13, e0195655.

86.

Hino, H., Shiomi, A., Kusuhara, M., Kagawa, H., Yamakawa, Y., Hatakeyama, K.,
Kawabata, T., Oishi, T., Urakami, K., Nagashima, T. et al. (2019)
Clinicopathological and mutational analyses of colorectal cancer with mutations
in the POLE gene. Cancer Med., 8, 4587-4597.

87.

Hussein, Y.R., Weigelt, B., Levine, D.A., Schoolmeester, J.K., Dao, L.N., Balzer,
B.L., Liles, G., Karlan, B., Kobel, M., Lee, C.H. et al. (2015) Clinicopathological
analysis of endometrial carcinomas harboring somatic POLE exonuclease
domain mutations. Mod. Pathol., 28, 505-514.

88.

Imboden, S., Nastic, D., Ghaderi, M., Rydberg, F., Rau, T.T., Mueller, M.D.,
Epstein, E. and Carlson, J.W. (2019) Phenotype of POLE-mutated endometrial
cancer. PLoS One, 14, e0214318.

97
89.

Levine, D.A., The Cancer Genome Atlas Research, N., Getz, G., Gabriel, S.B.,
Cibulskis, K., Lander, E., Sivachenko, A., Sougnez, C., Lawrence, M., Kandoth,
C. et al. (2013) Integrated genomic characterization of endometrial carcinoma.
Nature, 497, 67.

90.

Cancer Genome Research Network. (2012) Comprehensive molecular
characterization of human colon and rectal cancer. Nature, 487, 330-337.

91.

Cancer Genome Research Network, Kandoth, C., Schultz, N., Cherniack, A.D.,
Akbani, R., Liu, Y., Shen, H., Robertson, A.G., Pashtan, I., Shen, R. et al. (2013)
Integrated genomic characterization of endometrial carcinoma. Nature, 497, 6773.

92.

Stenzinger, A., Pfarr, N., Endris, V., Penzel, R., Jansen, L., Wolf, T., Herpel, E.,
Warth, A., Klauschen, F., Kloor, M. et al. (2014) Mutations in POLE and survival
of colorectal cancer patients--link to disease stage and treatment. Cancer Med.,
3, 1527-1538.

93.

Yao, J., Gong, Y., Zhao, W., Han, Z., Guo, S., Liu, H., Peng, X., Xiao, W., Li, Y.,
Dang, S. et al. (2019) Comprehensive analysis of POLE and POLD1 Gene
Variations identifies cancer patients potentially benefit from immunotherapy in
Chinese population. Sci. Rep., 9, 15767.

94.

Yu, S., Shao, H., Ban, X., Zhang, H., You, Y., Zhou, N., Mao, X., Zhao, H., Chen,
J. and Lu, Z. (2019) Detection of POLE Subtypes in High-Grade Endometrioid
Carcinoma by BaseScope-ISH Assay. Front. Oncol., 9, 831.

95.

Rayner, E., van Gool, I.C., Palles, C., Kearsey, S.E., Bosse, T., Tomlinson, I. and
Church, D.N. (2016) A panoply of errors: polymerase proofreading domain
mutations in cancer. Nat. Rev. Cancer, 16, 71-81.

96.

Park, V.S. and Pursell, Z.F. (2019) POLE proofreading defects: Contributions to
mutagenesis and cancer. DNA Repair (Amst), 76, 50-59.

97.

Church, D.N., Stelloo, E., Nout, R.A., Valtcheva, N., Depreeuw, J., ter Haar, N.,
Noske, A., Amant, F., Tomlinson, I.P., Wild, P.J. et al. (2015) Prognostic
significance of POLE proofreading mutations in endometrial cancer. J. Natl.
Cancer Inst., 107, 402.

98.

Ahn, S.M., Ansari, A.A., Kim, J., Kim, D., Chun, S.M., Kim, J., Kim, T.W., Park, I.,
Yu, C.S. and Jang, S.J. (2016) The somatic POLE P286R mutation defines a
unique subclass of colorectal cancer featuring hypermutation, representing a
potential genomic biomarker for immunotherapy. Oncotarget, 7, 68638-68649.

99.

Kothari, N., Teer, J.K., Abbott, A.M., Srikumar, T., Zhang, Y., Yoder, S.J., Brohl,
A.S., Kim, R.D., Reed, D.R. and Shibata, D. (2016) Increased incidence of
FBXW7 and POLE proofreading domain mutations in young adult colorectal
cancers. Cancer, 122, 2828-2835.

100.

Meng, B., Hoang, L.N., McIntyre, J.B., Duggan, M.A., Nelson, G.S., Lee, C.H.
and Kobel, M. (2014) POLE exonuclease domain mutation predicts long

98
progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
Gynecol. Oncol., 134, 15-19.
101.

Erson-Omay, E.Z., Caglayan, A.O., Schultz, N., Weinhold, N., Omay, S.B.,
Ozduman, K., Koksal, Y., Li, J., Serin Harmanci, A., Clark, V. et al. (2015)
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma
subtype with better prognosis. Neuro Oncol., 17, 1356-1364.

102.

Miyamoto, T., Ando, H., Asaka, R., Yamada, Y. and Shiozawa, T. (2018)
Mutation analysis by whole exome sequencing of endometrial hyperplasia and
carcinoma in one patient: Abnormalities of polymerase epsilon and the
phosphatidylinositol-3 kinase pathway. J. Obstet. Gynaecol. Res., 44, 179-183.

103.

Temko, D., Van Gool, I.C., Rayner, E., Glaire, M., Makino, S., Brown, M.,
Chegwidden, L., Palles, C., Depreeuw, J., Beggs, A. et al. (2018) Somatic POLE
exonuclease domain mutations are early events in sporadic endometrial and
colorectal carcinogenesis, determining driver mutational landscape, clonal
neoantigen burden and immune response. J. Pathol., 245, 283-296.

104.

Haradhvala, N.J., Kim, J., Maruvka, Y.E., Polak, P., Rosebrock, D., Livitz, D.,
Hess, J.M., Leshchiner, I., Kamburov, A., Mouw, K.W. et al. (2018) Distinct
mutational signatures characterize concurrent loss of polymerase proofreading
and mismatch repair. Nat. Commun., 9, 1746.

105.

Campbell, B.B., Light, N., Fabrizio, D., Zatzman, M., Fuligni, F., de Borja, R.,
Davidson, S., Edwards, M., Elvin, J.A., Hodel, K.P. et al. (2017) Comprehensive
analysis of hypermutation in human cancer. Cell, 171, 1042-1056 e1010.

106.

Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S.,
Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L. et al. (2013)
Signatures of mutational processes in human cancer. Nature, 500, 415-421.

107.

Bellone, S., Centritto, F., Black, J., Schwab, C., English, D., Cocco, E., Lopez, S.,
Bonazzoli, E., Predolini, F., Ferrari, F. et al. (2015) Polymerase epsilon (POLE)
ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in
endometrial cancer patients. Gynecol. Oncol., 138, 11-17.

108.

Eggink, F.A., Van Gool, I.C., Leary, A., Pollock, P.M., Crosbie, E.J., Mileshkin, L.,
Jordanova, E.S., Adam, J., Freeman-Mills, L., Church, D.N. et al. (2017)
Immunological profiling of molecularly classified high-risk endometrial cancers
identifies POLE-mutant and microsatellite unstable carcinomas as candidates for
checkpoint inhibition. Oncoimmunology, 6, e1264565.

109.

Howitt, B.E., Shukla, S.A., Sholl, L.M., Ritterhouse, L.L., Watkins, J.C., Rodig, S.,
Stover, E., Strickland, K.C., D'Andrea, A.D., Wu, C.J. et al. (2015) Association of
Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With
Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of
PD-1 and PD-L1. JAMA Oncol., 1, 1319-1323.

110.

van Gool, I.C., Eggink, F.A., Freeman-Mills, L., Stelloo, E., Marchi, E., de Bruyn,
M., Palles, C., Nout, R.A., de Kroon, C.D., Osse, E.M. et al. (2015) POLE

99
Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial
Cancer. Clin. Cancer. Res., 21, 3347-3355.
111.

Bakhsh, S., Kinloch, M., Hoang, L.N., Soslow, R.A., Kobel, M., Lee, C.H.,
McAlpine, J.N., McConechy, M.K. and Gilks, C.B. (2016) Histopathological
features of endometrial carcinomas associated with POLE mutations:
implications for decisions about adjuvant therapy. Histopathology, 68, 916-924.

112.

Bellone, S., Bignotti, E., Lonardi, S., Ferrari, F., Centritto, F., Masserdotti, A.,
Pettinella, F., Black, J., Menderes, G., Altwerger, G. et al. (2017) Polymerase
epsilon (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte
infiltration and increased resistance to platinum-based chemotherapy in vitro.
Gynecol. Oncol., 144, 146-152.

113.

Liu, L., Ruiz, J., O'Neill, S.S., Grant, S.C., Petty, W.J., Yang, M., Chen, K.,
Topaloglu, U., Pasche, B. and Zhang, W. (2018) Favorable outcome of patients
with lung adenocarcinoma harboring POLE mutations and expressing high PDL1. Mol. Cancer, 17, 81.

114.

Wang, C., Gong, J., Tu, T.Y., Lee, P.P. and Fakih, M. (2018) Immune profiling of
microsatellite instability-high and polymerase epsilon (POLE)-mutated metastatic
colorectal tumors identifies predictors of response to anti-PD-1 therapy. J.
Gastrointest. Oncol., 9, 404-415.

115.

Mehnert, J.M., Panda, A., Zhong, H., Hirshfield, K., Damare, S., Lane, K., Sokol,
L., Stein, M.N., Rodriguez-Rodriquez, L., Kaufman, H.L. et al. (2016) Immune
activation and response to pembrolizumab in POLE-mutant endometrial cancer.
J. Clin. Invest., 126, 2334-2340.

116.

Santin, A.D., Bellone, S., Buza, N., Choi, J., Schwartz, P.E., Schlessinger, J. and
Lifton, R.P. (2016) Regression of Chemotherapy-Resistant Polymerase epsilon
(POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with
Nivolumab. Clin. Cancer. Res., 22, 5682-5687.

117.

Forbes, S.A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H.,
Ding, M., Bamford, S., Cole, C., Ward, S. et al. (2015) COSMIC: exploring the
world's knowledge of somatic mutations in human cancer. Nucleic Acids Res.,
43, D805-811.

118.

Kane, D.P. and Shcherbakova, P.V. (2014) A common cancer-associated DNA
polymerase ε mutation causes an exceptionally strong mutator phenotype,
indicating fidelity defects distinct from loss of proofreading. Cancer Res., 74,
1895-1901.

119.

Albertson, T.M., Ogawa, M., Bugni, J.M., Hays, L.E., Chen, Y., Wang, Y.,
Treuting, P.M., Heddle, J.A., Goldsby, R.E. and Preston, B.D. (2009) DNA
polymerase ε and δ proofreading suppress discrete mutator and cancer
phenotypes in mice. Proc. Natl. Acad. Sci. U.S.A., 106, 17101-17104.

120.

Li, H.D., Cuevas, I., Zhang, M., Lu, C., Alam, M.M., Fu, Y.X., You, M.J., Akbay,
E.A., Zhang, H. and Castrillon, D.H. (2018) Polymerase-mediated

100
ultramutagenesis in mice produces diverse cancers with high mutational load. J.
Clin. Invest., 128, 4179-4191.
121.

Hodel, K.P., Sun, M.J.S., Ungerleider, N., Park, V.S., Williams, L.G., Bauer, D.L.,
Immethun, V.E., Wang, J., Suo, Z., Lu, H. et al. (2020) POLE Mutation Spectra
Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair
Status. Mol. Cell.

122.

Abaan, O.D., Polley, E.C., Davis, S.R., Zhu, Y.J., Bilke, S., Walker, R.L., Pineda,
M., Gindin, Y., Jiang, Y., Reinhold, W.C. et al. (2013) The exomes of the NCI-60
panel: a genomic resource for cancer biology and systems pharmacology.
Cancer Res., 73, 4372-4382.

123.

Hodel, K.P., de Borja, R., Henninger, E.E., Campbell, B.B., Ungerleider, N.,
Light, N., Wu, T., LeCompte, K.G., Goksenin, A.Y., Bunnell, B.A. et al. (2018)
Explosive mutation accumulation triggered by heterozygous human Pol ε
proofreading-deficiency is driven by suppression of mismatch repair. Elife, 7.

124.

Parkash, V., Kulkarni, Y., ter Beek, J., Shcherbakova, P.V., Kamerlin, S.C.L. and
Johansson, E. (2019) Structural consequence of the most frequently recurring
cancer-associated substitution in DNA polymerase ε. Nat. Commun., 10, 373.

125.

Kirchner, J.M., Tran, H. and Resnick, M.A. (2000) A DNA polymerase ε mutant
that specifically causes +1 frameshift mutations within homonucleotide runs in
yeast. Genetics, 155, 1623-1632.

126.

Kokoska, R.J., Stefanovic, L., Tran, H.T., Resnick, M.A., Gordenin, D.A. and
Petes, T.D. (1998) Destabilization of yeast micro- and minisatellite DNA
sequences by mutations affecting a nuclease involved in Okazaki fragment
processing (rad27) and DNA polymerase δ (pol3-t). Mol. Cell. Biol., 18, 27792788.

127.

Li, L., Murphy, K.M., Kanevets, U. and Reha-Krantz, L.J. (2005) Sensitivity to
phosphonoacetic acid: a new phenotype to probe DNA polymerase δ in
Saccharomyces cerevisiae. Genetics, 170, 569-580.

128.

Shcherbakova, P.V. and Pavlov, Y.I. (1993) Mutagenic specificity of the base
analog 6-N-hydroxylaminopurine in the URA3 gene of the yeast Saccharomyces
cerevisiae. Mutagenesis, 8, 417-421.

129.

Pavlov, Y.I., Newlon, C.S. and Kunkel, T.A. (2002) Yeast origins establish a
strand bias for replicational mutagenesis. Mol. Cell, 10, 207-213.

130.

Morrison, A. and Sugino, A. (1994) The 3'-->5' exonucleases of both DNA
polymerases δ and ε participate in correcting errors of DNA replication in
Saccharomyces cerevisiae. Mol. Gen. Genet., 242, 289-296.

131.

Shcherbakova, P.V., Noskov, V.N., Pshenichnov, M.R. and Pavlov, Y.I. (1996)
Base analog 6-N-hydroxylaminopurine mutagenesis in the yeast Saccharomyces
cerevisiae is controlled by replicative DNA polymerases. Mutat. Res., 369, 33-44.

101
132.

Tran, H.T., Keen, J.D., Kricker, M., Resnick, M.A. and Gordenin, D.A. (1997)
Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase
proofreading yeast mutants. Mol. Cell. Biol., 17, 2859-2865.

133.

Shcherbakova, P.V. and Kunkel, T.A. (1999) Mutator phenotypes conferred by
MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol. Cell. Biol.,
19, 3177-3183.

134.

Mertz, T.M., Sharma, S., Chabes, A. and Shcherbakova, P.V. (2015) Colon
cancer-associated mutator DNA polymerase δ variant causes expansion of dNTP
pools increasing its own infidelity. Proc. Natl. Acad. Sci. U.S.A., 112, E24672476.

135.

Northam, M.R., Robinson, H.A., Kochenova, O.V. and Shcherbakova, P.V.
(2010) Participation of DNA polymerase ζ in replication of undamaged DNA in
Saccharomyces cerevisiae. Genetics, 184, 27-42.

136.

Whelan, W.L., Gocke, E. and Manney, T.R. (1979) The CAN1 locus of
Saccharomyces cerevisiae: fine-structure analysis and forward mutation rates.
Genetics, 91, 35-51.

137.

Drake, J.W. (1991) A constant rate of spontaneous mutation in DNA-based
microbes. Proc. Natl. Acad. Sci. U.S.A., 88, 7160-7164.

138.

Dixon, W.J. (1969) Introduction to statistical analysis. Macgraw Hillkogakusha,
Tokyo.

139.

Ohya, T., Kawasaki, Y., Hiraga, S., Kanbara, S., Nakajo, K., Nakashima, N.,
Suzuki, A. and Sugino, A. (2002) The DNA polymerase domain of pol ε is
required for rapid, efficient, and highly accurate chromosomal DNA replication,
telomere length maintenance, and normal cell senescence in Saccharomyces
cerevisiae. J. Biol. Chem., 277, 28099-28108.

140.

Pavlov, Y.I., Maki, S., Maki, H. and Kunkel, T.A. (2004) Evidence for interplay
among yeast replicative DNA polymerases α, δ and ε from studies of
exonuclease and polymerase active site mutations. BMC Biol., 2, 11.

141.

Lee, M.B., Dowsett, I.T., Carr, D.T., Wasko, B.M., Stanton, S.G., Chung, M.S.,
Ghodsian, N., Bode, A., Kiflezghi, M.G., Uppal, P.A. et al. (2019) Defining the
impact of mutation accumulation on replicative lifespan in yeast using cancerassociated mutator phenotypes. Proc. Natl. Acad. Sci. U.S.A., 116, 3062-3071.

142.

Morrison, A., Johnson, A.L., Johnston, L.H. and Sugino, A. (1993) Pathway
correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J., 12,
1467-1473.

143.

Pavlov, Y.I., Shcherbakova, P.V. and Kunkel, T.A. (2001) In vivo consequences
of putative active site mutations in yeast DNA polymerases α, ε, δ, and ζ.
Genetics, 159, 47-64.

102
144.

Pavlov, Y.I. and Shcherbakova, P.V. (2010) DNA polymerases at the eukaryotic
fork-20 years later. Mutat. Res., 685, 45-53.

145.

Williams, L.N., Herr, A.J. and Preston, B.D. (2013) Emergence of DNA
polymerase ε antimutators that escape error-induced extinction in yeast.
Genetics, 193, 751-770.

146.

Flood, C.L., Rodriguez, G.P., Bao, G., Shockley, A.H., Kow, Y.W. and Crouse,
G.F. (2015) Replicative DNA polymerase δ but not ε proofreads errors in cis and
in trans. PLoS Genet., 11, e1005049.

147.

Perrino, F.W. and Loeb, L.A. (1989) Proofreading by the ε subunit of Escherichia
coli DNA polymerase III increases the fidelity of calf thymus DNA polymerase α.
Proc. Natl. Acad. Sci. U.S.A., 86, 3085-3088.

148.

Perrino, F.W. and Loeb, L.A. (1990) Hydrolysis of 3'-terminal mispairs in vitro by
the 3'----5' exonuclease of DNA polymerase δ permits subsequent extension by
DNA polymerase α. Biochemistry, 29, 5226-5231.

149.

Belyakova, N.V., Kleiner, N.E., Kravetskaya, T.P., Legina, O.K., Naryzhny, S.N.,
Perrino, F.W., Shevelev, I.V. and Krutyakov, V.M. (1993) Proof-reading 3'-->5'
exonucleases isolated from rat liver nuclei. Eur. J. Biochem., 217, 493-500.

150.

Huang, P. (1998) Excision of mismatched nucleotides from DNA: a potential
mechanism for enhancing DNA replication fidelity by the wild-type p53 protein.
Oncogene, 17, 261-270.

151.

Brown, K.R., Weatherdon, K.L., Galligan, C.L. and Skalski, V. (2002) A nuclear
3'-5' exonuclease proofreads for the exonuclease-deficient DNA polymerase α.
DNA Repair (Amst), 1, 795-810.

152.

McCulloch, S.D., Kokoska, R.J., Chilkova, O., Welch, C.M., Johansson, E.,
Burgers, P.M. and Kunkel, T.A. (2004) Enzymatic switching for efficient and
accurate translesion DNA replication. Nucleic Acids Res., 32, 4665-4675.

153.

Fuchs, R.P. and Fujii, S. (2007) Translesion synthesis in Escherichia coli:
lessons from the NarI mutation hot spot. DNA Repair (Amst), 6, 1032-1041.

154.

Datta, A., Schmeits, J.L., Amin, N.S., Lau, P.J., Myung, K. and Kolodner, R.D.
(2000) Checkpoint-dependent activation of mutagenic repair in Saccharomyces
cerevisiae pol3-01 mutants. Mol. Cell, 6, 593-603.

155.

Marsischky, G.T., Filosi, N., Kane, M.F. and Kolodner, R. (1996) Redundancy of
Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch
repair. Genes Dev., 10, 407-420.

156.

Aparicio, O.M., Weinstein, D.M. and Bell, S.P. (1997) Components and dynamics
of DNA replication complexes in S. cerevisiae: redistribution of MCM proteins
and Cdc45p during S phase. Cell, 91, 59-69.

103
157.

Muramatsu, S., Hirai, K., Tak, Y.S., Kamimura, Y. and Araki, H. (2010) CDKdependent complex formation between replication proteins Dpb11, Sld2, Pol ε,
and GINS in budding yeast. Genes Dev., 24, 602-612.

158.

Chilkova, O., Stenlund, P., Isoz, I., Stith, C.M., Grabowski, P., Lundstrom, E.B.,
Burgers, P.M. and Johansson, E. (2007) The eukaryotic leading and lagging
strand DNA polymerases are loaded onto primer-ends via separate mechanisms
but have comparable processivity in the presence of PCNA. Nucleic Acids Res.,
35, 6588-6597.

159.

Grabowska, E., Wronska, U., Denkiewicz, M., Jaszczur, M., Respondek, A.,
Alabrudzinska, M., Suski, C., Makiela-Dzbenska, K., Jonczyk, P. and
Fijalkowska, I.J. (2014) Proper functioning of the GINS complex is important for
the fidelity of DNA replication in yeast. Mol. Microbiol., 92, 659-680.

160.

Fijalkowska, I.J., Jonczyk, P., Tkaczyk, M.M., Bialoskorska, M. and Schaaper,
R.M. (1998) Unequal fidelity of leading strand and lagging strand DNA replication
on the Escherichia coli chromosome. Proc. Natl. Acad. Sci. U.S.A., 95, 1002010025.

161.

Bulock, C.R., Xing, X. and Shcherbakova, P.V. (2020) DNA polymerase δ
proofreads errors made by DNA polymerase ε. Proc. Natl. Acad. Sci. U.S.A.,
117, 6035-6041.

162.

Herr, A.J., Kennedy, S.R., Knowels, G.M., Schultz, E.M. and Preston, B.D.
(2014) DNA replication error-induced extinction of diploid yeast. Genetics, 196,
677-691.

163.

Reddy, M.K., Weitzel, S.E. and von Hippel, P.H. (1992) Processive proofreading
is intrinsic to T4 DNA polymerase. J. Biol. Chem., 267, 14157-14166.

164.

Fidalgo da Silva, E. and Reha-Krantz, L.J. (2007) DNA polymerase proofreading:
active site switching catalyzed by the bacteriophage T4 DNA polymerase.
Nucleic Acids Res., 35, 5452-5463.

165.

Boiteux, S. and Jinks-Robertson, S. (2013) DNA repair mechanisms and the
bypass of DNA damage in Saccharomyces cerevisiae. Genetics, 193, 10251064.

166.

Sharma, S., Helchowski, C.M. and Canman, C.E. (2013) The roles of DNA
polymerase ζ and the Y family DNA polymerases in promoting or preventing
genome instability. Mutat. Res., 743-744, 97-110.

167.

Jansen, J.G., Temviriyanukul, P., Wit, N., Delbos, F., Reynaud, C.A., Jacobs, H.
and de Wind, N. (2014) Redundancy of mammalian Y family DNA polymerases
in cellular responses to genomic DNA lesions induced by ultraviolet light. Nucleic
Acids Res., 42, 11071-11082.

168.

Hosoya, N. and Miyagawa, K. (2014) Targeting DNA damage response in cancer
therapy. Cancer Sci., 105, 370-388.

104
169.

Choi, J.S., Kim, S., Motea, E. and Berdis, A. (2017) Inhibiting translesion DNA
synthesis as an approach to combat drug resistance to DNA damaging agents.
Oncotarget, 8, 40804-40816.

170.

Choi, J.S. and Berdis, A. (2018) Combating resistance to DNA damaging agents.
Oncoscience, 5, 134-136.

171.

Manhart, C.M. and Alani, E. (2017) DNA replication and mismatch repair
safeguard against metabolic imbalances. Proc. Natl. Acad. Sci. U.S.A., 114,
5561-5563.

172.

Schmidt, T.T., Reyes, G., Gries, K., Ceylan, C.U., Sharma, S., Meurer, M., Knop,
M., Chabes, A. and Hombauer, H. (2017) Alterations in cellular metabolism
triggered by URA7 or GLN3 inactivation cause imbalanced dNTP pools and
increased mutagenesis. Proc. Natl. Acad. Sci. U.S.A., 114, E4442-E4451.

173.

Barbari, S.R., Kane, D.P., Moore, E.A. and Shcherbakova, P.V. (2018)
Functional analysis of cancer-associated DNA polymerase ε variants in
Saccharomyces cerevisiae. G3 (Bethesda), 8, 1019-1029.

174.

Shlien, A., Campbell, B.B., de Borja, R., Alexandrov, L.B., Merico, D., Wedge, D.,
Van Loo, P., Tarpey, P.S., Coupland, P., Behjati, S. et al. (2015) Combined
hereditary and somatic mutations of replication error repair genes result in rapid
onset of ultra-hypermutated cancers. Nat. Genet., 47, 257-262.

175.

Goldsby, R.E., Lawrence, N.A., Hays, L.E., Olmsted, E.A., Chen, X., Singh, M.
and Preston, B.D. (2001) Defective DNA polymerase-δ proofreading causes
cancer susceptibility in mice. Nat. Med., 7, 638-639.

176.

Goldsby, R.E., Hays, L.E., Chen, X., Olmsted, E.A., Slayton, W.B., Spangrude,
G.J. and Preston, B.D. (2002) High incidence of epithelial cancers in mice
deficient for DNA polymerase δ proofreading. Proc. Natl. Acad. Sci. U.S.A., 99,
15560-15565.

105

Appendix A: Yeast strains used to study extrinsic
proofreading

Single-mutant
strains
crossed to
make diploids

Relevant
genotypes of
segregants
used to
measure
mutation
rates

Strain name

Genotype

Source

CB404

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2
leu2-3,112 ura3-52 pol2-4

This work

CB405

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2
leu2-3,112 ura3-52 pol2-M644G

This work

CB414

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3-4 pol3-D520V

This work

CB415

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3-4 pol3-L612M

This work

CB420

(POL2 POL3)

This work

CB421

pol2-4

This work

CB422

pol2-M644G

This work

CB423

pol3-D520V

This work

CB424

pol3-L612M

This work

CB425

pol2-4 pol3-L612M

This work

CB426

pol2-M644G pol3-D520V

This work
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Appendix B: Yeast strains used for replicon studies
Strain name
CG379Δ
n306::ura3-29inv
or1
CG379Δ
n306::ura3-29inv
or2

ura3-29
reporter
strains
POL2

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or1
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or2

Source
Kochenova and
Shcherbakova,
unpublished
Kochenova and
Shcherbakova,
unpublished

CG379-3-29RL

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29RL

(58,143)

CG29LR

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29LR

(58)

CB105

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or1

This work

CB106

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or2

This work

CB107

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or1

This work

CB108

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or2

This work

CB109

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or1

This work

CB110

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or2

This work

CG379Δ
atg22::ura3-29 or1

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or1

CG379Δ
atg22::ura3-29 or2

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or2

Kochenova and
Shcherbakova,
unpublished
Kochenova and
Shcherbakova,
unpublished
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Strain name
CG379Δ
n306::ura3-29inv
or1 pol2-4
CG379Δ
n306::ura3-29inv
or2 pol2-4

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or2
pol2-4

CG379-3-29RL
pol2-4

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29RL pol2-4

This work

CG29LR pol2-4

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29LR pol2-4

This work

CB105 pol2-4
ura3-29
reporter
strains
pol2-4

CB106 pol2-4
CB107 pol2-4
CB108 pol2-4
CB109 pol2-4
CB110 pol2-4
CG379Δ
atg22::ura3-29 or1
pol2-4
CG379Δ
atg22::ura3-29 or2
pol2-4

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or2
pol2-4

Source
This work
This work

This work
This work
This work
This work
This work
This work
This work
This work
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Strain name
CG379Δ
n306::ura3-29inv
or1 pol2-P301R
CG379Δ
n306::ura3-29inv
or2 pol2-P301R
CG379-3-29RL
pol2-P301R
CG29LR pol2P301R
CB105 pol2-P301R
ura3-29
reporter
strains
pol2-P301R

CB106 pol2-P301R
CB107 pol2-P301R
CB108 pol2-P301R
CB109 pol2-P301R
CB110 pol2-P301R
CG379Δ
atg22::ura3-29 or1
pol2-P301R
CG379Δ
atg22::ura3-29 or2
pol2-P301R

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or1
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-29::LEU2or2
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29RL pol2P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-29LR pol2P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or1
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-29::LEU2or2
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or1
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-29::LEU2or2
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or1
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-29::LEU2or2
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or1
pol2-P301R
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-29::LEU2or2
pol2-P301R

Source
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
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ura3-24
reporter
strains
POL2

Strain name

Genotype

Source

CB201

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or1

This work

CB202

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or2

This work

CB203

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or1

This work

CB204

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or2

This work

CB205

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or1

This work

CB206

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or2

This work

CB207

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or1

This work

CB208

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or2

This work

CB209

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or1

This work

CB210

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or2

This work

CB211

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or1

This work

CB212

MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or2

This work
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Strain name
CB201 pol2-4
CB202 pol2-4
CB203 pol2-4
CB204 pol2-4
CB205 pol2-4
ura3-24
reporter
strains
pol2-4

CB206 pol2-4
CB207 pol2-4
CB208 pol2-4
CB209 pol2-4
CB210 pol2-4
CB211 pol2-4
CB212 pol2-4

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or2
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or1
pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or2
pol2-4

Source
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
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Strain name
CB301
CB302
CB303
CB304
CB305
ura3-24
reporter
strains
msh6Δ
POL2

CB306
CB307
CB308
CB309
CB310
CB311
CB312

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or2
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or2
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or2
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or2
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or2
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or1
msh6Δ::kanMX
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or2
msh6Δ::kanMX

Source
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
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Strain name
CB301 pol2-4
CB302 pol2-4
CB303 pol2-4
CB304 pol2-4
CB305 pol2-4
ura3-24
reporter
strains
msh6Δ
pol2-4

CB306 pol2-4
CB307 pol2-4
CB308 pol2-4
CB309 pol2-4
CB310 pol2-4
CB311 pol2-4
CB312 pol2-4

Genotype
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ hbn1Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ bik1Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ his4Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ ste50Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ lsb5Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or1
msh6Δ::kanMX pol2-4
MATα ade5-1 lys2-Tn5-13 trp1-289 his7-2
leu2-3,112 ura3Δ atg22Δ::ura3-24::LEU2or2
msh6Δ::kanMX pol2-4

Source
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
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Appendix C: Yeast strains used to study correction of
Polε-P301R errors

Haploid strains
used to make
diploids

Strain name

Genotype

Source

TM30

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2 leu2-3,112
ura3-4 CAN1::Kl.LEU2

(134)

CB401

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2 leu2-3,112
ura3-4 CAN1::Kl.LEU2 pol2-4

This work

CB402

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2 leu2-3,112
ura3-4 CAN1::Kl.LEU2 pol2-P301R

This work

CB403

MATa ade5-1 lys2-Tn5-13 trp1-289 his7-2 leu2-3,112
ura3-4 CAN1::Kl.LEU2 pol3-D520V

This work

TM44

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2 leu23,112 ura3-52 can1Δ::loxP

(134)

CB323

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2 leu23,112 ura3-52 can1Δ::loxP msh6Δ::kanMX

This work

CB411

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2 leu23,112 ura3-52 can1Δ::loxP pol2-4

This work

CB412

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2 leu23,112 ura3-52 can1Δ::loxP pol2-P301R

This work

CB413

MATα ade5-1 lys2::InsEA14 trp1-289 his7-2 leu23,112 ura3-52 can1Δ::loxP pol3-D520V

This work
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Strain name

CB615

pBL304
plasmid loss
strains

CB616

CB617

CB618

Genotype
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn513 trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu23,112 ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
pol2-P301R/pol2-P301R pol3-D520V/pol3-D520V
[pBL304]
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn513 trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu23,112 ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
pol3-D520V/pol3-D520V [pBL304]
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn513 trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu23,112 ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
pol2-P301R/pol2-P301R [pBL304]
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn513 trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu23,112 ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
[pBL304]

Source

This work

This work

This work

This work
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Strain name
CB511

CB512

CB513

Interaction of
Polδ
proofreading
deficiency and
Polε variants

CB514

CB515

CB613

CB711

CB712

Genotype
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol24/POL2 pol3-D520V/POL3
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol2P301R/POL2 pol3-D520V/POL3
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol24/POL2
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol2P301R/POL2
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol3D520V/POL3
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol3D520V/pol3-D520V
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol24/POL2 pol3-D520V/pol3-D520V
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2 pol2P301R/POL2 pol3-D520V/pol3-D520V

Source
This work

This work

This work

This work

This work

This work

This work

This work

116
Strain name

Genotype

Source

TM63

MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2

(134)

CB326
Interaction of
MMR
deficiency and
polymerase
variants

CB331

CB341

CB352

MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
msh6Δ::kanMX/msh6Δ::kanMX
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
msh6Δ::kanMX/msh6Δ::kanMX POL2/pol2-P301R
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
msh6Δ::kanMX/msh6Δ::kanMX POL2/pol2-4
MATa/MATα ade5-1/ade5-1 lys2-InsEA14/lys2-Tn5-13
trp1-289/trp1-289 his7-2/his7-2 leu2-3,112/leu2-3,112
ura3-52/ura3-4 can1Δ::loxP/CAN1::Kl.LEU2
msh6Δ::kanMX/msh6Δ::kanMX pol3-D520V/pol3D520V

This work

This work

This work

This work

